###begin article-title 0
###xml 50 55 50 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1</italic>
###xml 57 61 57 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5</italic>
###xml 66 71 66 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
###xml 114 121 114 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 125 133 125 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Disease-Influencing Effects Associated with ZNRD1, HCP5 and HLA-C Alleles Are Attributable Mainly to Either HLA-A10 or HLA-B*57 Alleles
###end article-title 0
###begin p 1
Conceived and designed the experiments: GC HK WH MJD SKA. Performed the experiments: GC WH VT SL. Analyzed the data: GC HK WH SL JC RAC MJD SKA. Contributed reagents/materials/analysis tools: VM BA ML SAA JD JC MJD SKA. Wrote the paper: GC HK WH ML JC RAC MJD SKA.
###end p 1
###begin p 2
###xml 98 102 98 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5</italic>
###xml 104 109 104 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
###xml 114 119 114 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1</italic>
###xml 783 788 783 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1</italic>
###xml 792 797 792 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
###xml 802 806 802 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5</italic>
###xml 869 876 869 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 881 890 881 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57-</italic>
###xml 927 932 927 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1</italic>
###xml 949 956 949 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 999 1008 999 1008 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-A10</italic>
###xml 1057 1063 1057 1063 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5-G</italic>
###xml 1214 1218 1214 1218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 1224 1230 1224 1230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5-G</italic>
###xml 1330 1336 1330 1336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5-G</italic>
###xml 1437 1441 1437 1441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 1464 1468 1464 1468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5</italic>
###xml 1473 1478 1473 1478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
###xml 1496 1500 1496 1500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 1683 1691 1683 1691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 2022 2027 2022 2027 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1</italic>
###xml 2085 2092 2085 2092 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 2136 2140 2136 2140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5</italic>
###xml 2142 2147 2142 2147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
###xml 2152 2160 2152 2160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 2202 2210 2202 2210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 2266 2270 2266 2270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 147 152 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 274 277 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 392 395 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 622 627 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 637 644 <span type="species:ncbi:9606">persons</span>
###xml 2222 2225 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
A recent genome-wide association study (GWAS) suggested that polymorphisms in or around the genes HCP5, HLA-C and ZNRD1 confer restriction against HIV-1 viral replication or disease progression. Here, we also find that these alleles are associated with different aspects of HIV disease, albeit mainly in European Americans. Additionally, we offer that because the GWAS cohort was a subset of HIV-positive individuals, selected based in part on having a low viral load, the observed associations for viral load are magnified compared with those we detect in a large well-characterized prospective natural history cohort of HIV-1-infected persons. We also find that because of linkage disequilibrium (LD) patterns, the dominant viral load- and disease-influencing associations for the ZNRD1 or HLA-C and HCP5 alleles are apparent mainly when these alleles are present in HLA-A10- or HLA-B*57-containing haplotypes, respectively. ZNRD1 alleles lacking HLA-A10 did not confer disease protection whereas ZNRD1-A10 haplotypes did. When examined in isolation, the HCP5-G allele associates with a slow disease course and lower viral loads. However, in multivariate models, after partitioning out the protective effects of B*57, the HCP5-G allele associates with disease-acceleration and enhanced viral replication; these associations for HCP5-G are otherwise obscured because of the very strong LD between this allele and a subset of protective B*57 alleles. Furthermore, HCP5 and HLA-C alleles stratify B*57-containing genotypes into those that associate with either striking disease retardation or progressive disease, providing one explanation for the long-standing conundrum of why some HLA-B*57-carrying individuals are long-term non-progressors, whereas others exhibit progressive disease. Collectively, these data generally underscore the strong dependence of genotype-phenotype relationships upon cohort design, phenotype selection, LD patterns and populations studied. They specifically demonstrate that the influence of ZNRD1 alleles on disease progression rates are attributable to HLA-A10, help clarify the relationship between the HCP5, HLA-C and HLA-B*57 alleles, and reaffirm a critical role of HLA-B*57 alleles in HIV disease. Furthermore, as the protective B*57-containing genotypes convey striking salutary effects independent of their strong impact on viral control, it is conceivable that T cell-based therapeutic vaccine strategies aimed at reducing viral loads may be inadequate for limiting AIDS progression, raising the potential need for complementary strategies that target viral load-independent determinants of pathogenesis.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 319 327 319 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 378 381 378 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Johnston1">[1]</xref>
###xml 383 386 383 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Desrosiers1">[2]</xref>
###xml 388 391 388 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Walker1">[3]</xref>
###xml 642 645 642 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Walker1">[3]</xref>
###xml 647 650 647 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Moore1">[4]</xref>
###xml 652 655 652 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Sekaly1">[5]</xref>
###xml 657 660 657 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Cohen1">[6]</xref>
###xml 1054 1057 1054 1057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-1">[7]</xref>
###xml 1059 1062 1059 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Gilbert1">[8]</xref>
###xml 1064 1067 1064 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Gilbert2">[9]</xref>
###xml 1069 1073 1069 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Gupta1">[10]</xref>
###xml 21 26 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 126 129 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 371 377 <span type="species:ncbi:9606">humans</span>
###xml 474 479 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 521 526 <span type="species:ncbi:9606">human</span>
###xml 576 582 <span type="species:ncbi:9606">humans</span>
###xml 812 815 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 847 852 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
An important goal of HIV-1 vaccine research is to identify vaccine-induced immune responses that will predict protection from HIV infection or disease. However, this is proving to be an immensely complex task because it is difficult to predict which immunological response(s) in candidate vaccine-challenged animals or in vitro studies will convey a protective effect in humans [1], [2], [3]. This is exemplified by the results of the recent STEP trial, which showed that a HIV-1 vaccine that conferred protection in non-human primates not only failed to confer protection in humans, but may have paradoxically increased risk of transmission [3], [4], [5], [6]. This vaccine failure provides greater urgency for determining the precise repertoire of host genetic factors that influence three parameters: risk of HIV acquisition, extent of initial HIV-1 replication (as reflected by the steady-state viral load), and rate of disease progression. This is because these three parameters also may have utility as endpoints for evaluation of vaccine efficacy [7], [8], [9], [10].
###end p 4
###begin p 5
###xml 187 190 187 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 295 299 295 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Smith1">[11]</xref>
###xml 404 407 404 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 467 469 467 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Smith1">11</xref>
###xml 471 473 471 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Carrington1">12</xref>
###xml 475 477 475 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Gao1">13</xref>
###xml 479 481 479 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Stephens1">14</xref>
###xml 483 485 483 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Kaslow1">15</xref>
###xml 487 489 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Goulder1">16</xref>
###xml 491 493 491 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Hunt1">17</xref>
###xml 495 497 495 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Telenti1">18</xref>
###xml 512 520 512 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 624 627 624 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 709 713 709 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 806 810 806 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Smith1">[11]</xref>
###xml 812 816 812 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Carrington1">[12]</xref>
###xml 818 822 818 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Stephens1">[14]</xref>
###xml 824 828 824 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Kaslow1">[15]</xref>
###xml 830 834 830 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Hunt1">[17]</xref>
###xml 836 840 836 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Migueles1">[19]</xref>
###xml 842 846 842 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Migueles2">[20]</xref>
###xml 848 852 848 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Altfeld1">[21]</xref>
###xml 854 858 854 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Navis1">[22]</xref>
###xml 1039 1042 1039 1042 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 1200 1203 1200 1203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Johnston1">[1]</xref>
###xml 1205 1208 1205 1208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Desrosiers1">[2]</xref>
###xml 1210 1214 1210 1214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Anderson1">[23]</xref>
###xml 1216 1220 1216 1220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Blower1">[24]</xref>
###xml 1222 1226 1222 1226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-AbuRaddad1">[25]</xref>
###xml 1228 1232 1228 1232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Amirfar1">[26]</xref>
###xml 162 167 <span type="species:ncbi:9606">Human</span>
###xml 445 448 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 574 577 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 668 671 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 922 925 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
In this quest to identify the correlates of protection that might have relevance for vaccine development, the immunological features linked to alleles of class I Human Leukocyte Antigen (HLA) genes, which reside in the Major Histocompatibility Complex (MHC) locus, may be especially informative [11]. This is because genetic association studies have provided incontrovertible evidence demonstrating that HLA alleles are critical determinants of HIV-AIDS pathogenesis 11, 12, 13, 14, 15, 16, 17, 18. For example, HLA-B*57 is among the most intensively studied alleles in the HIV-AIDS field as it is among the most protective HLA class I alleles. In multiple cohorts of HIV-positive individuals possession of a B*57 allele is associated with a slower rate of disease progression and strong virologic control [11], [12], [14], [15], [17], [19], [20], [21], [22]. Thus, it is conceivable that administration of a therapeutic (HIV disease-retarding) vaccine that elicits immunologic features similar to those associated with disease protective HLA class I alleles might have benefit in terms of reducing population-level viral load, and consequently, as modeling studies suggest, the pace of the epidemic [1], [2], [23], [24], [25], [26].
###end p 5
###begin p 6
###xml 18 21 18 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 300 304 300 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Fellay1">[27]</xref>
###xml 387 388 387 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 562 566 562 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Fellay1">[27]</xref>
###xml 662 666 662 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Fellay1">[27]</xref>
###xml 754 762 754 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 834 837 834 837 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 846 848 846 848 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P5</italic>
###xml 850 854 850 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5</italic>
###xml 904 909 904 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
###xml 915 919 915 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Fellay1">[27]</xref>
###xml 1058 1064 1058 1064 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNF39)</italic>
###xml 1102 1107 1102 1107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1</italic>
###xml 1146 1151 1146 1151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A</italic>
###xml 1158 1162 1158 1162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Fellay1">[27]</xref>
###xml 44 47 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 384 387 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 615 618 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The importance of HLA alleles in control of HIV replication is further illustrated by the results of a recent genome wide association study (GWAS) because nearly 50% of the top 50 single nucleotide polymorphisms (SNPs) that associated with virologic control were in or around the MHC locus at 6p21.3 [27]. The selection criteria of subjects for the GWAS were based on a therapy-naive HIV+ individual of European descent achieving a steady-state viral load or having a stable low viral load (<1,000 RNA copies/ml), without knowledge of the date of seroconversion [27]. 486 subjects met this criteria from the 30,000 HIV-positive subjects screened retrospectively [27]. The two SNPs that had the strongest association with virologic control were both near HLA-B*57: the first was a SNP in an endogenous retroviral element designated as HLA complex P5 (HCP5), and the second SNP was in the 5'-region of the HLA-C gene [27]. Also implicated as major determinants of AIDS progression rates were seven SNPs in and around the genes encoding ring finger protein 39 (RNF39) and zinc ribbon domain-containing 1 (ZNRD1), which are in close proximity to the HLA-A locus [27].
###end p 6
###begin p 7
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
###xml 59 64 59 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1</italic>
###xml 194 198 194 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5</italic>
###xml 280 288 280 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 373 383 373 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*5701</italic>
###xml 601 604 601 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 130 133 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 440 443 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 544 547 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Thus, the main inferences of this GWAS were: (i) HLA-C and ZNRD1 are key independent host determinants associated with control of HIV replication and disease progression, respectively, and (ii) HCP5 may contribute positively to the well-described protective effects attributed to HLA-B*57, as this allele was found to be in nearly 100% linkage disequilibrium (LD) with the HLA-B*5701 allele. This GWAS clearly represents an advance for the HIV-AIDS field, and the results served as a fulcrum to probe further the importance of the MHC locus in HIV-AIDS pathogenesis. To understand further the role of HLA alleles in AIDS pathogenesis we reflected on the following three points.
###end p 7
###begin p 8
###xml 19 23 19 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5</italic>
###xml 28 33 28 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
###xml 148 152 124 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Fellay1">[27]</xref>
###xml 268 272 244 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Mellors1">[28]</xref>
###xml 274 278 250 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Mellors2">[29]</xref>
###xml 391 395 367 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Fellay1">[27]</xref>
###xml 438 443 414 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
###xml 630 634 606 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Fellay1">[27]</xref>
###xml 661 665 637 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5</italic>
###xml 770 773 746 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 774 780 750 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*5701</italic>
###xml 914 918 890 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Kaslow1">[15]</xref>
###xml 920 924 896 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Hunt1">[17]</xref>
###xml 926 930 902 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Migueles1">[19]</xref>
###xml 932 936 908 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Altfeld1">[21]</xref>
###xml 938 942 914 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Fellay1">[27]</xref>
###xml 944 948 920 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Gaudieri1">[30]</xref>
###xml 1005 1010 981 986 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
###xml 1015 1019 991 995 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5</italic>
###xml 1222 1226 1198 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Deeks1">[31]</xref>
###xml 1206 1209 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1729 1734 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
First, the SNPs in HCP5 and HLA-C accounted for approximately9.6% and approximately6.5% of the variability in steady-state viral load, respectively [27]. Despite these high percentages and the prior observation that viral load is highly predictive of clinical outcome [28], [29], these polymorphisms were not among those identified when disease progression was used as a phenotypic endpoint [27]. For example, the association between the HLA-C allele and viral load exceeded the threshold for statistical significance imposed by a GWAS, but the association of this allele for disease progression was not statistically significant [27]. Additionally, the SNP in HCP5 was not identified in the GWAS screen for disease progression, despite being in nearly 100% LD with the HLA-B*5701 allele, which in multiple cohorts has been associated with better virologic control, as well as a slower rate of disease progression [15], [17], [19], [21], [27], [30]. These observations (strong association for the SNPs in HLA-C and HCP5 for viral load, but not for disease progression) suggested that perhaps epidemiological considerations, such as the combined analyses of subjects who achieve steady-state viral load and HIV controllers [31], might have inadvertently led to an enrichment of subjects with genotypes that might confer enhanced restriction of viral replication, and under-representation of individuals who have progressive disease during the early stages of infection. Hence, alleles that might associate with disease acceleration may not be fully represented in the study sample examined, and conceivably, this may obscure genotype-phenotype associations that might be detected within the context of a natural history cohort of HIV-1-infected subjects.
###end p 8
###begin p 9
###xml 71 74 71 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 83 87 83 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-deBakker1">[32]</xref>
###xml 89 93 89 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Miretti1">[33]</xref>
###xml 194 198 194 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5</italic>
###xml 200 205 200 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
###xml 210 216 210 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1)</italic>
###xml 253 256 253 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 438 442 438 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Gonzalez1">[34]</xref>
###xml 444 448 444 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Winkler1">[35]</xref>
###xml 450 454 450 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Gonzalez2">[36]</xref>
###xml 389 392 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Second, there is a high degree of LD between SNPs in the MHC locus and HLA alleles [32], [33]. It thus remained conceivable that the effects attributed to the three SNPs identified in the GWAS (HCP5, HLA-C and ZNRD1) were due, in part, to their LD with HLA class I alleles that affect viral load and/or disease course. Third, we and others have shown that the host genetic determinants of HIV-AIDS pathogenesis may be population-specific [34], [35], [36]. Since the GWAS was restricted to subjects of European descent, we considered whether the reported SNPs also influenced other populations.
###end p 9
###begin p 10
###xml 402 406 402 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Gonzalez1">[34]</xref>
###xml 408 412 408 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Gonzalez2">[36]</xref>
###xml 414 418 414 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Gonzalez3">[37]</xref>
###xml 420 424 420 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Ahuja1">[38]</xref>
###xml 426 430 426 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Dolan1">[39]</xref>
###xml 509 513 509 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5</italic>
###xml 515 520 515 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
###xml 525 530 525 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1</italic>
###xml 583 586 583 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 316 321 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
For these three reasons, we sought to achieve greater clarity regarding the phenotypic effects associated with the SNPs in the three genes identified in the GWAS on steady-state viral load and disease progression rates. We conducted these analyses in a large, well-characterized U.S.-based natural history cohort of HIV-1-positive individuals, whose clinical characteristics have been described before [34], [36], [37], [38], [39]. We evaluated the genotype-phenotype associations attributable to the SNPs in HCP5, HLA-C and ZNRD1 before and after accounting for patterns of LD with HLA alleles that were in close proximity to these SNPs in the entire cohort, and separately in subjects of European and African descent.
###end p 10
###begin title 11
Results
###end title 11
###begin title 12
LD patterns of SNPs with HLA alleles
###end title 12
###begin p 13
###xml 16 17 16 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 25 26 25 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 100 104 100 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5</italic>
###xml 131 139 131 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5-T&gt;G</italic>
###xml 163 168 163 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
###xml 200 206 200 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 207 211 207 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-T&gt;C</italic>
###xml 259 264 259 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1</italic>
###xml 269 274 269 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNF39</italic>
###xml 282 291 282 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g001">Figure 1A</xref>
###xml 348 349 348 349 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 361 364 361 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 381 385 381 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Ahuja1">[38]</xref>
###xml 479 482 479 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 505 506 505 506 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 544 549 544 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1</italic>
###xml 710 719 710 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g001">Figure 1B</xref>
###xml 724 733 724 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g001">Figure 1C</xref>
###xml 927 932 927 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1</italic>
###xml 1021 1026 1021 1026 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1</italic>
###xml 1045 1056 1045 1056 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-RNF39</italic>
###xml 1070 1079 1070 1079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g001">Figure 1B</xref>
###xml 1084 1093 1084 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g001">Figure 1C</xref>
###xml 1152 1161 1152 1161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-T&gt;C</italic>
###xml 13 16 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 22 25 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 345 348 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 502 505 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 623 626 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
We genotyped HIV+ and HIV- subjects in the Wilford Hall Medical Center (WHMC) cohort for the SNP in HCP5 (rs2395029; designated as HCP5-T>G), the 5'-region of the HLA-C gene (rs9264942, designated as HLA-C5'-T>C), as well as for the seven SNPs in or near the ZNRD1 and RNF39 genes (Figure 1A). We had previously genotyped subjects from the WHMC HIV+ cohort for HLA class I alleles [38]. We evaluated the pair-wise patterns of LD between the SNPs, as well as between the SNPs and HLA class I alleles in HIV+ individuals. The seven SNPs near the ZNRD1 locus that were found to be associated with inter-subject differences in HIV disease course in the GWAS were all found to be in nearly 100% LD with each other (Figure 1B and Figure 1C, bottom). Predictably, consistent with these very high LD patterns, the genotype-phenotype associations reported below did not differ significantly when we analyzed each of the seven SNPs near ZNRD1 separately (data not shown). Hence, the results reported here are for a single SNP near ZNRD1 (rs9261174; third ZNRD1-RNF39 SNP shown in Figure 1B and Figure 1C, bottom), and this polymorphism is designated here as the ZNRD1-T>C SNP.
###end p 13
###begin title 14
###xml 65 66 65 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 62 65 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Polymorphisms analyzed in this study and their LD patterns in HIV+ subjects from the WHMC cohort.
###end title 14
###begin p 15
###xml 102 106 102 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5</italic>
###xml 108 113 108 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNF39</italic>
###xml 118 123 118 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1</italic>
###xml 151 154 151 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 436 443 434 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 468 472 454 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 743 751 717 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 753 757 727 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5</italic>
###xml 762 768 736 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 810 817 784 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 822 827 796 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1</italic>
###xml 857 858 831 832 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 939 953 913 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57, HCP5</italic>
###xml 958 964 932 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 1095 1102 1069 1076 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 1107 1112 1081 1086 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1</italic>
###xml 1454 1459 1428 1433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1</italic>
###xml 1464 1469 1438 1443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNF39</italic>
###xml 1512 1517 1486 1491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1</italic>
###xml 854 857 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
(A) Genomic location of the polymorphisms studied on chromosome 6p21. Green ticks/boxes represent the HCP5, RNF39 and ZNRD1 genes and red ticks denote HLA loci. The relative location of the polymorphisms studied is shown by vertical arrows (along with their respective NCBI rs identifiers). The horizontal arrows under the genes point to the 5'-->3' orientation of the gene. The predicted size of the two extended haplotypes containing HLA-A10 (approximately86kb) and B*57 (approximately157kb) are also shown. (B) Linkage disequilibrium (LD) analysis of the studied alleles. D' value estimates are denoted by the intensity of the blue color shown on the scale on the top. (C) Estimated frequencies of the haplotypes based on possession of the HLA-B*57, HCP5 and HLA-C5' polymorphisms (top), and separately for HLA-A10 and ZNRD1 (bottom) polymorphisms in HIV+ individuals from the WHMC cohort. Top panel shows the haplotype frequencies for HLA-B*57, HCP5 and HLA-C5' alleles (red and purple colored bars are for EAs and AAs, respectively) while the lower panel is for haplotypes derived based on HLA-A10 and ZNRD1 polymorphisms (red and purple colored bars are for EAs and AAs, respectively). Bars represent the haplotype frequency while the numbers to the right of each bar represents the number of haplotypes found in the WHMC subjects. Numbers in parentheses, total number of haplotypes. As discussed in the text, because of the nearly 100% LD between ZNRD1 and RNF39 SNPs, rs9261129 was used to represent the ZNRD1 SNP in statistical analyses (SNP number 3 in panels B and panel C, bottom).
###end p 15
###begin p 16
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A</italic>
###xml 54 59 54 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1</italic>
###xml 65 74 65 74 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1A</bold>
###xml 65 74 65 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g001"><bold>Figure 1A</bold></xref>
###xml 150 155 150 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A</italic>
###xml 210 214 210 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-deBakker1">[32]</xref>
###xml 243 253 243 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A*2601</italic>
###xml 358 369 358 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-RFN39</italic>
###xml 589 594 589 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1</italic>
###xml 613 621 613 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A*26</italic>
###xml 637 641 637 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A*25</italic>
###xml 660 668 660 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A*34</italic>
###xml 673 681 673 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A*66</italic>
###xml 704 711 704 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 711 715 711 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Joysey1">[40]</xref>
###xml 717 726 717 726 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1B</bold>
###xml 717 726 717 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g001"><bold>Figure 1B</bold></xref>
###xml 731 740 731 740 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1C</bold>
###xml 731 740 731 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g001"><bold>Figure 1C</bold></xref>
###xml 740 741 740 741 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">,</bold>
###xml 769 770 769 770 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 785 792 785 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 822 830 822 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A*25</italic>
###xml 835 843 835 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A*26</italic>
###xml 895 902 895 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 951 959 951 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A*34</italic>
###xml 964 972 964 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A*66</italic>
###xml 1024 1031 1024 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 1086 1093 1086 1093 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 1097 1109 1097 1109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003636.s001">Materials S1</xref>
###xml 1093 1109 1093 1109 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> in <xref ref-type="supplementary-material" rid="pone.0003636.s001">Materials S1</xref></bold>
###xml 1178 1185 1178 1185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 1246 1247 1246 1247 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1289 1290 1287 1288 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1299 1300 1297 1298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1309 1312 1307 1310 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;15</sup>
###xml 766 769 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1243 1246 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The spatial proximity between the HLA-A locus and the ZNRD1 SNP (Figure 1A) prompted us to investigate whether the latter SNP was in LD with specific HLA-A alleles. We considered the results of de Bakker et al [32] who found a high LD between HLA-A*2601 and the SNP designated as rs2301751. The latter SNP is 244 bp from rs2301753, which is one of the seven ZNRD1-RFN39 SNPs that we genotyped. Furthermore, rs2301753 is reported to be in very high LD (D' = 1.0) with rs2301751 by the HapMap project in Utah residents of European descent. Accordingly, we found a very strong LD between the ZNRD1 SNP with not only HLA-A*26, but also with A*25, which along with HLA-A*34 and HLA-A*66 make up the serogroup HLA-A10[40] (Figure 1B and Figure 1C, bottom). Among the WHMC HIV+ subjects, the HLA-A10 group was composed mainly of HLA-A*25 and HLA-A*26 alleles (89% of the alleles that categorize to the HLA-A10 serogroup) in European Americans (EAs), whereas HLA-A*34 and HLA-A*66 alleles (78% of the alleles that categorize to the HLA-A10 serogroup) were more common in African Americans (AA; Table 1 in Materials S1). This difference in the distribution of alleles that belong to the HLA-A10 serogroup across the two major ethnic groups in the WHMC HIV+ cohort was statistically significant (chi2 = 72.7; P = 1.1x10-15).
###end p 16
###begin p 17
###xml 40 44 40 44 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Fellay1">[27]</xref>
###xml 85 89 85 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5</italic>
###xml 98 104 98 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*5701</italic>
###xml 106 115 106 115 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1B</bold>
###xml 106 115 106 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g001"><bold>Figure 1B</bold></xref>
###xml 120 127 120 127 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 2</bold>
###xml 131 143 131 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003636.s001">Materials S1</xref>
###xml 127 143 127 143 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> in <xref ref-type="supplementary-material" rid="pone.0003636.s001">Materials S1</xref></bold>
###xml 198 204 198 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5-G</italic>
###xml 206 212 206 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 213 215 213 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-C</italic>
###xml 220 228 220 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 246 252 246 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 254 255 254 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 256 271 256 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57/HCP5-G</italic>
###xml 345 354 345 354 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1B</bold>
###xml 345 354 345 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g001"><bold>Figure 1B</bold></xref>
###xml 359 368 359 368 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1C</bold>
###xml 359 368 359 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g001"><bold>Figure 1C</bold></xref>
###xml 493 500 493 500 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 3</bold>
###xml 504 516 504 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003636.s001">Materials S1</xref>
###xml 500 516 500 516 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> in <xref ref-type="supplementary-material" rid="pone.0003636.s001">Materials S1</xref></bold>
###xml 451 454 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Consistent with the results of the GWAS [27], a nearly 100% LD was noted between the HCP5 SNP and B*5701 (Figure 1B and Table 2 in Materials S1). Moreover, there was a high degree of LD between the HCP5-G, HLA-C5'-C and HLA-B*57 alleles, and the HLA-C5'-C/HLA-B*57/HCP5-G-containing haplotype was found almost exclusively in European Americans (Figure 1B and Figure 1C, top). No significant differences were found in the frequency of these SNPs among HIV-infected and -uninfected individuals (Table 3 in Materials S1).
###end p 17
###begin p 18
###xml 137 142 137 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1</italic>
###xml 146 150 146 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5</italic>
###xml 155 160 155 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
###xml 181 188 181 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 193 201 193 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
Because of the observed LD patterns, in the analyses described below, we examined whether the influence on disease course of the SNPs in ZNRD1 or HCP5 and HLA-C were independent of HLA-A10 and HLA-B*57, respectively.
###end p 18
###begin title 19
###xml 24 27 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Effects of ZNRD1 SNP on HIV disease
###end title 19
###begin p 20
###xml 32 33 32 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 88 95 88 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C</italic>
###xml 144 153 144 153 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2A</bold>
###xml 144 165 144 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g002"><bold>Figure 2A</bold>, left panel</xref>
###xml 348 355 348 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C</italic>
###xml 393 402 393 402 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2A</bold>
###xml 393 402 393 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g002"><bold>Figure 2A</bold></xref>
###xml 402 403 402 403 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">,</bold>
###xml 496 500 496 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Fellay1">[27]</xref>
###xml 520 527 520 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C</italic>
###xml 29 32 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 670 673 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 692 695 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
In the entire cohort of WHMC HIV+ subjects, heterozygosity but not homozygosity for the ZNRD1-C allele was associated with disease-retardation (Figure 2A, left panel). We stratified the cohort based on whether subjects were EAs or African Americans (AAs), and the stratified analysis revealed that the disease-retarding effects associated with the ZNRD1-C allele was restricted mainly to EAs (Figure 2A, middle and right panel). These results are consistent with the observations by Fellay et al [27] who found that the ZNRD1-C allele is associated with a slower disease course in subjects of European descent. However, we also found that this allele does not influence HIV disease course in HIV-positive African Americans in the WHMC cohort.
###end p 20
###begin title 21
###xml 44 51 44 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 52 57 52 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1</italic>
Disease-influencing effects associated with HLA-A10/ZNRD1-containing genotypes.
###end title 21
###begin p 22
###xml 103 108 103 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1</italic>
###xml 366 373 366 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 647 658 647 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCL3L1-CCR5</italic>
###xml 813 820 813 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 836 841 836 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1</italic>
###xml 1198 1205 1198 1205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 1210 1217 1210 1217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C</italic>
###xml 1267 1280 1267 1280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10/ZNRD1</italic>
###xml 1370 1377 1370 1377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 1382 1389 1382 1389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C</italic>
###xml 1442 1455 1442 1455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10/ZNRD1</italic>
###xml 1492 1493 1487 1488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1608 1609 1603 1604 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1633 1634 1628 1629 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1669 1670 1662 1663 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1688 1689 1681 1682 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 1702 1703 1695 1696 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1794 1795 1785 1786 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1855 1859 1846 1850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Dolan1">[39]</xref>
###xml 1893 1895 1884 1886 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 2073 2077 2062 2066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Dolan1">[39]</xref>
###xml 1340 1343 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1896 1899 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
(A) Plots are Kaplan-Meier curves for time to AIDS (1987 criteria). Disease-influencing effects of the ZNRD1 SNP in all subjects (left column), and in the European American (middle column) and African American (right column) components of the WHMC cohort. (B) Kaplan-Meier plots depicting the influence on rate of disease progression of alleles categorized into the HLA-A10 serogroup. The relative hazards (RH) and 95% confidence intervals (CI) were computed before (values above the complete horizontal line) and after (values below the complete horizontal line) adjustment for ethnic background, cohort membership across different therapy eras, CCL3L1-CCR5 genetic risk group status and whether date of seroconversion was known. (C) Six genotypic groups (enumerated, color-coded) were derived by accounting for HLA-A10 status and the ZNRD1 genotype. Number of subjects in each genotypic group are shown within the color-coded boxes. (D) Kaplan-Meier plot for the disease-influencing effects of the six genotypic groups (Gp) shown in panel C. RH, CI, and significance values are depicted to the right and were obtained by Cox proportional hazards modeling. n, number of subjects. Group 1 (Lacking HLA-A10 and ZNRD1-C) is used as a reference. (E) Association between HLA-A10/ZNRD1-containing genotypes with virologic-immunologic markers of HIV disease. Group 1 (lacking HLA-A10 and ZNRD1-C) is used as a reference and comparisons are made to HLA-A10/ZNRD1 genotypic groups 2 and 5. daggerM-W P refers to significance values obtained by Mann-Whitney test. bCD4, nCD4, and cCD4 represent baseline and nadir CD4+ T cell counts (cells/mm3, mean (+/-SE)), and cumulative CD4+ T cell count (x105 cell-days/mm3, mean (+/-SE)), respectively; the latter parameter provides a measure of the change in CD4+ T cell count during disease course as described previously [39]. VL, steady-state viral load (log10 HIV mRNA copies/ml, mean (+/-SE)). DTH, delayed type hypersensitivity skin test reactivity (an in vivo parameter of cell-mediated immunity) was examined as described previously [39] and data reflect the mean (+/-SE) number of positive skin tests out of the four applied.
###end p 22
###begin p 23
###xml 77 84 77 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C</italic>
###xml 153 160 153 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 201 208 201 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C</italic>
###xml 236 243 236 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 245 254 245 254 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1B</bold>
###xml 245 254 245 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g001"><bold>Figure 1B</bold></xref>
###xml 259 268 259 268 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1C</bold>
###xml 259 268 259 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g001"><bold>Figure 1C</bold></xref>
###xml 364 367 364 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A10</italic>
###xml 409 416 409 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C</italic>
###xml 437 444 437 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C</italic>
###xml 529 530 529 530 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 536 545 536 545 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2A</bold>
###xml 536 545 536 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g002"><bold>Figure 2A</bold></xref>
###xml 567 568 567 568 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 616 623 616 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 747 750 747 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A10</italic>
###xml 762 771 762 771 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2B</bold>
###xml 762 771 762 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g002"><bold>Figure 2B</bold></xref>
###xml 797 804 797 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 847 848 847 848 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 964 971 964 971 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 1149 1153 1149 1153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Dolan1">[39]</xref>
###xml 1155 1164 1155 1164 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2B</bold>
###xml 1155 1164 1155 1164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g002"><bold>Figure 2B</bold></xref>
###xml 1222 1229 1222 1229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 1417 1418 1417 1418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1474 1481 1474 1481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 1483 1492 1483 1492 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure S1</bold>
###xml 1483 1492 1483 1492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003636.s002"><bold>Figure S1</bold></xref>
###xml 1527 1534 1527 1534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 1539 1546 1539 1546 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C</italic>
###xml 1623 1630 1623 1630 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C</italic>
###xml 1674 1681 1674 1681 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 1751 1758 1751 1758 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C</italic>
###xml 1802 1805 1802 1805 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A10</italic>
###xml 1853 1854 1853 1854 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1900 1905 1900 1905 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1</italic>
###xml 1906 1907 1906 1907 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1922 1929 1922 1929 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 1938 1947 1938 1947 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2C</bold>
###xml 1938 1947 1938 1947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g002"><bold>Figure 2C</bold></xref>
###xml 1969 1976 1969 1976 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C</italic>
###xml 1981 1988 1981 1988 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 2051 2060 2051 2060 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2C</bold>
###xml 2051 2060 2051 2060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g002"><bold>Figure 2C</bold></xref>
###xml 292 295 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 526 529 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 564 567 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 844 847 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1850 1853 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
We next determined whether the disease retarding effects associated with the ZNRD1-C allele were due to those associated with alleles categorized to the HLA-A10 serogroup for three reasons. First, the ZNRD1-C allele was in high LD with HLA-A10 (Figure 1B and Figure 1C, bottom) and of the 60 HIV-positive EAs who possessed an allele corresponding to the serogroup A10, 52 subjects also possessed at least one ZNRD1-C allele. Second, the ZNRD1-C allele was associated with a reduced rate of disease progression to AIDS only in HIV+ EAs (Figure 2A). Similarly, only HIV+ EAs who possessed alleles corresponding to the HLA-A10 serogroup had a significantly slower rate of progression to AIDS compared to those who lacked alleles corresponding to the A10 serogroup (Figure 2B). An association between HLA-A10 and disease course was not detected in HIV+ AA (data not shown). Notably, the strength of the disease-retarding effects (relative hazards, RH) associated with HLA-A10 were similar before (RH = 0.62) and after (RH = 0.44) adjustment for explanatory covariates that in previous studies we had found influenced disease progression in this cohort ([39]; Figure 2B). The strength of the protective effects associated with HLA-A10 were also consistent when the analysis was restricted to subjects who had not received highly active antiretroviral therapy (HAART) (RH = 0.52; 95% confidence interval (CI) = 0.028-0.93; P = 0.028 for comparison of those possessing and lacking HLA-A10; Figure S1). Third, we surmised that if both HLA-A10 and ZNRD1-C each had independent effects on disease, then the protective effects of the ZNRD1-C allele that are not because of its LD with HLA-A10 should be evident in those 85 individuals who possessed at least one ZNRD1-C allele but lacked alleles corresponding to A10 serogroup. For these reasons, we stratified HIV+ EAs into six genotypic groups based on their ZNRD1-C allele and/or HLA-A10 status (Figure 2C). Those lacking both ZNRD1-C and HLA-A10 served as the reference category in the statistical analyses (Figure 2C, group 1).
###end p 23
###begin p 24
###xml 24 31 24 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C</italic>
###xml 51 58 51 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 60 69 60 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2C</bold>
###xml 60 69 60 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g002"><bold>Figure 2C</bold></xref>
###xml 155 162 155 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C</italic>
###xml 167 174 167 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 228 235 228 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C</italic>
###xml 303 304 303 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 322 331 322 331 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2D</bold>
###xml 322 331 322 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g002"><bold>Figure 2D</bold></xref>
###xml 431 438 431 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C</italic>
###xml 445 451 445 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-10</italic>
###xml 511 520 511 520 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2D</bold>
###xml 511 520 511 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g002"><bold>Figure 2D</bold></xref>
###xml 574 575 574 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 597 598 597 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 682 689 682 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 706 713 706 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C</italic>
###xml 813 816 813 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A10</italic>
###xml 834 841 834 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C</italic>
###xml 850 859 850 859 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2D</bold>
###xml 850 859 850 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g002"><bold>Figure 2D</bold></xref>
###xml 937 944 937 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C</italic>
###xml 1018 1025 1018 1025 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 1066 1073 1066 1073 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C</italic>
###xml 1122 1129 1122 1129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 1242 1249 1242 1249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C</italic>
###xml 1268 1275 1268 1275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 1277 1278 1277 1278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1323 1330 1323 1330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C</italic>
###xml 1335 1342 1335 1342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 1344 1345 1344 1345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1352 1361 1352 1361 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2D</bold>
###xml 1352 1361 1352 1361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g002"><bold>Figure 2D</bold></xref>
###xml 1410 1417 1410 1417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 1476 1483 1476 1483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 1488 1493 1488 1493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1</italic>
###xml 1494 1495 1494 1495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 300 303 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1207 1210 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Subjects possessing one ZNRD1-C allele but lacking HLA-A10 (Figure 2C, group 2) had a disease course that was indistinguishable from those who lacked both ZNRD1-C and HLA-A10 alleles (group 1). This suggested that in itself the ZNRD1-C allele was not associated with disease-retarding effects in the HIV+ EAs we examined (Figure 2D, compare survival curves for genotypic groups 1 and 2). By contrast, subjects who possessed both a ZNRD1-C and a HLA-10 allele (group 5) had a slower rate of disease progression (Figure 2D, compare survival curves for group 5 versus group 1 (P = 0.004) or group 2 (P = 0.057)). Additionally, although the number of subjects was small, those who were HLA-A10+ but lacked the ZNRD1-C allele (group 4) also had a slower disease course that was comparable to those in group 5 who were A10+ but possessed a ZNRD1-C allele (Figure 2D). These data indicated that the disease-retarding effect associated with the ZNRD1-C allele is evident only when it resides on a haplotype that also contains HLA-A10. The failure to detect an effect of the ZNRD1-C allele on disease course that is independent of HLA-A10 did not appear to be due to insufficient sample size because there were more HIV-positive EAs who possessed one ZNRD1-C allele but lacked HLA-A10 (n = 83) than those who had one allele each of ZNRD1-C and HLA-A10 (n = 50; Figure 2D). Furthermore, similar to what was observed for HLA-A10, the associations for the six genotypic groups defined by HLA-A10 and ZNRD1-C genotypes remained consistent when the analysis was restricted to subjects who had not received HAART (data not shown).
###end p 24
###begin p 25
###xml 53 60 53 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C</italic>
###xml 141 150 141 150 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2A</bold>
###xml 141 150 141 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g002"><bold>Figure 2A</bold></xref>
###xml 191 192 191 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 264 271 264 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C</italic>
###xml 305 312 305 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 438 447 438 447 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2D</bold>
###xml 438 447 438 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g002"><bold>Figure 2D</bold></xref>
###xml 547 556 547 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-A10</italic>
###xml 615 622 615 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C</italic>
###xml 725 732 725 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
The survival curves associated with homozygosity for ZNRD1-C suggested that it might be associated with a rapid rate of disease progression (Figure 2A, middle; RH = 4.26; 95% CI = 1.36-13.3; P = 0.013). Although there were few subjects who were homozygous for the ZNRD1-C allele with (group 6) or without HLA-A10 (group 3), it was interesting to note that subjects assigned to either of these two groups had a progressive disease course (Figure 2D). The small sample sizes preclude firm inferences but the direction of the effects associated with ZNRD1-A10 genotypic groups 3and 6 suggest that homozygosity for the ZNRD1-C allele might associate with disease acceleration even in those instances when these genotypes contain HLA-A10 alleles.
###end p 25
###begin p 26
###xml 21 30 21 30 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2D</bold>
###xml 21 30 21 30 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g002"><bold>Figure 2D</bold></xref>
###xml 65 72 65 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 77 84 77 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C</italic>
###xml 188 201 188 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10/ZNRD1</italic>
###xml 287 296 287 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A10-ZNRD1</italic>
###xml 317 326 317 326 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1C</bold>
###xml 317 326 317 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g001"><bold>Figure 1C</bold></xref>
###xml 431 440 431 440 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure S2</bold>
###xml 431 440 431 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003636.s003"><bold>Figure S2</bold></xref>
###xml 508 515 508 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C</italic>
###xml 624 631 624 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 679 686 679 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C</italic>
###xml 704 711 704 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 713 722 713 722 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1C</bold>
###xml 713 722 713 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g001"><bold>Figure 1C</bold></xref>
###xml 893 903 893 903 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure S2B</bold>
###xml 893 903 893 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003636.s003"><bold>Figure S2B</bold></xref>
###xml 1013 1020 1013 1020 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C</italic>
###xml 1025 1032 1025 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 1047 1056 1047 1056 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1C</bold>
###xml 1047 1056 1047 1056 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g001"><bold>Figure 1C</bold></xref>
###xml 1123 1133 1123 1133 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure S2C</bold>
###xml 1123 1133 1123 1133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003636.s003"><bold>Figure S2C</bold></xref>
###xml 1249 1256 1249 1256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 1265 1272 1265 1272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C</italic>
###xml 1287 1296 1287 1296 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1C</bold>
###xml 1287 1296 1287 1296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g001"><bold>Figure 1C</bold></xref>
###xml 1370 1380 1370 1380 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure S2D</bold>
###xml 1370 1380 1370 1380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003636.s003"><bold>Figure S2D</bold></xref>
The results shown in Figure 2D were derived from the genotype of HLA-A10 and ZNRD1-C alleles. To confirm that the aforementioned inferences derived from the associations of these compound HLA-A10/ZNRD1 genotypes are valid, we determined the disease-influencing effects of the individual A10-ZNRD1 haplotypes shown in Figure 1C in the EA component of the WHMC cohort. The results of these analyses conducted at the haplotype level (Figure S2) provide further confirmation that the effects associated with the ZNRD1-C allele occur only when this allele is present on the same haplotype on which alleles that categorize to the HLA-A10 serogroup exists. First, haplotype 2 bears the ZNRD1-C allele but lacks HLA-A10 (Figure 1C, bottom), and in the heterozygous state this haplotype is not associated with disease retardation and in the homozygous state it is associated with disease acceleration (Figure S2B; reference category are those lacking haplotype 2). Second, heterozygosity for the haplotype that bears both ZNRD1-C and HLA-A10 (haplotype 3; Figure 1C, bottom) is associated with a slower rate of disease progression (Figure S2C; reference category are those lacking haplotype 3). Third, those who are heterozygous for the haplotype that bears HLA-A10 but not ZNRD1-C (haplotype 5; Figure 1C, bottom) have a slower disease course than those lacking this haplotype (Figure S2D).
###end p 26
###begin p 27
###xml 74 83 74 83 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2D</bold>
###xml 74 83 74 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g002"><bold>Figure 2D</bold></xref>
###xml 122 131 122 131 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure S2</bold>
###xml 122 131 122 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003636.s003"><bold>Figure S2</bold></xref>
###xml 190 197 190 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C</italic>
###xml 306 313 306 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C</italic>
###xml 350 357 350 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 451 458 451 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 509 516 509 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 573 580 573 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 610 617 610 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C</italic>
###xml 684 693 684 693 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2D</bold>
###xml 684 693 684 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g002"><bold>Figure 2D</bold></xref>
###xml 708 718 708 718 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure S2D</bold>
###xml 708 718 708 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003636.s003"><bold>Figure S2D</bold></xref>
###xml 748 755 748 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 800 807 800 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C</italic>
Taken together, the analyses conducted thus far at the compound genotype (Figure 2D) and haplotype/haplotype pair levels (Figure S2) together demonstrate that in the cohort we examined, the ZNRD1-C allele does not have independent disease protective effects, and instead, the associations observed for the ZNRD1-C allele occur because of its LD with HLA-A10, i.e, they are attributable to the disease-modifying effects of alleles corresponding to the HLA-A10 serogroup. Further underscoring the importance of HLA-A10 in AIDS pathogenesis in EAs is the observation that the HLA-A10-bearing haplotype that lacks ZNRD1-C, albeit low in frequency, is associated with disease retardation (Figure 2D, group 4, and Figure S2D). This suggests further that HLA-A10 influences AIDS pathogenesis independent of ZNRD1-C.
###end p 27
###begin p 28
###xml 28 33 28 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1</italic>
###xml 34 35 34 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 106 113 106 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 214 221 214 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C</italic>
###xml 249 256 249 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 335 342 335 342 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 335 342 335 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003636-t001"><bold>Table 1</bold></xref>
###xml 424 431 424 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 444 445 444 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 467 472 467 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1</italic>
###xml 487 488 487 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 564 571 564 571 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 564 571 564 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003636-t001"><bold>Table 1</bold></xref>
To further confirm that the ZNRD1-C allele does not influence disease independent of its association with HLA-A10, we conducted univariate and multivariate analyses. In univariate analyses, both heterozygosity for ZNRD1-C (RH = 0.69; P = 0.030) and HLA-A10 (RH = 0.46; P = 0.005) associated with a reduced rate of disease progression (Table 1 under the column designated as 'Time to AIDS'). However, in multivariate models, HLA-A10 (RH = 0.51; P = 0.028) but not the ZNRD1-C (RH = 0.85; P = 0.409) allele was associated with a reduced rate of disease progression (Table 1).
###end p 28
###begin title 29
###xml 48 55 48 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 67 72 67 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1</italic>
###xml 0 3 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
HIV disease-influencing effects associated with HLA-A10 status and ZNRD1 heterozygosity in European Americans.
###end title 29
###begin p 30
###xml 152 154 152 154 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
Results are from multivariate Cox proportional hazards regression (for the outcome of time to AIDS) and linear regression models (for the outcome of log10 steady-state viral load).
###end p 30
###begin p 31
RH, relative hazards; CI, confidence interval, Coeff, regression coefficient obtained from linear regression model
###end p 31
###begin p 32
###xml 1 2 1 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 82 83 82 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 139 146 139 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C</italic>
R2, the explained variability in steady-state viral loads was assessed using the R2 estimated by analysis of variance (ANOVA). Analysis of ZNRD1-C homozygosity was not included in this analysis because of the small sample number.
###end p 32
###begin p 33
###xml 173 180 173 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C</italic>
###xml 328 329 328 329 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 389 396 389 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C</italic>
###xml 418 425 418 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 481 488 481 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C</italic>
###xml 493 500 493 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 575 576 575 576 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 718 722 718 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Dolan1">[39]</xref>
###xml 725 734 725 734 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2E</bold>
###xml 725 734 725 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g002"><bold>Figure 2E</bold></xref>
###xml 781 796 781 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10/ZNRD1-C</italic>
###xml 979 980 979 980 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1039 1040 1039 1040 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1144 1148 1144 1148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Dolan1">[39]</xref>
###xml 1150 1159 1150 1159 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2E</bold>
###xml 1150 1159 1150 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g002"><bold>Figure 2E</bold></xref>
###xml 1233 1240 1233 1240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C</italic>
###xml 1317 1324 1317 1324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 1359 1374 1359 1374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10/ZNRD1-C</italic>
###xml 1556 1557 1556 1557 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1597 1598 1597 1598 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1613 1622 1613 1622 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2E</bold>
###xml 1613 1622 1613 1622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g002"><bold>Figure 2E</bold></xref>
###xml 1670 1679 1670 1679 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2D</bold>
###xml 1670 1679 1670 1679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g002"><bold>Figure 2D</bold></xref>
The aforementioned genotype-phenotype association analyses were conducted using AIDS (1987 criteria) as a phenotypic endpoint. Therefore, it was plausible that although the ZNRD1-C allele did not have a direct impact on disease progression rates to AIDS it influenced surrogate markers of disease (e.g., viral load, baseline CD4+ T cell count). However, we found that subjects who had one ZNRD1-C allele but lacked an HLA-A10 allele (group 2) were similar to those who lacked both ZNRD1-C and HLA-A10 alleles (group 1) with respect to their baseline, cumulative and nadir CD4+ T cell counts, as well as steady-state viral load and delayed type hypersensitivity skin test reactions (a measure of cell mediated immunity [39]) (Figure 2E). Subjects in group 5 (heterozygosity for the HLA-A10/ZNRD1-C-containing haplotype) were also similar to those in group 1 with respect to most of these laboratory and immunologic characteristics, except those in group 5 had lower cumulative CD4+ T cell counts, a parameter that reflects the amount of CD4+ T cell loss over disease course and is a parameter that is highly correlated with development of AIDS ([39]; Figure 2E). These findings conveyed two points: first, in the cohort examined, the ZNRD1-C allele was unlikely to have an impact on disease independent of its LD with HLA-A10; and second, the influence of the HLA-A10/ZNRD1-C-containing haplotype on disease course occurs independent of an impact on the viral load, and that the influence of this haplotype is restricted mainly to the rate and extent of CD4+ T cell loss (assessed by cumulative CD4+ T cell count; Figure 2E), and by extension, on AIDS progression rates (Figure 2D).
###end p 33
###begin p 34
###xml 48 55 48 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C</italic>
###xml 123 130 123 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C</italic>
###xml 135 142 135 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 412 417 412 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1</italic>
###xml 455 462 455 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 520 521 520 521 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 549 550 549 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 561 568 561 568 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 561 568 561 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003636-t001"><bold>Table 1</bold></xref>
To clarify further the relationship between the ZNRD1-C allele and steady-state viral load, we determined the influence of ZNRD1-C and HLA-A10 on viral load using univariate and multivariate linear regression analyses. In these analyses, the alleles were considered as independent variables and the steady-state viral load was considered as the dependent variable. These analyses revealed that the impact of the ZNRD1 allele on viral load was minimal and HLA-A10 had no influence on viral load (as reflected by the low R2 values and non-significant P values in Table 1 under column designated as 'Steady-state viral load').
###end p 34
###begin title 35
Effects of HLA-C and HCP5 on disease progression
###end title 35
###begin p 36
###xml 34 42 34 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 101 105 101 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 204 210 204 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 211 213 211 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-C</italic>
###xml 215 223 215 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 228 234 228 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5-G</italic>
###xml 244 253 244 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g001">Figure 1B</xref>
###xml 258 267 258 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g001">Figure 1C</xref>
###xml 337 342 337 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
###xml 347 351 347 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5</italic>
###xml 416 424 416 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 556 561 556 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1</italic>
###xml 566 573 566 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 656 664 656 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 666 672 666 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 678 682 678 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5</italic>
###xml 692 700 692 700 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3</bold>
###xml 692 700 692 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g003"><bold>Figure 3</bold></xref>
###xml 777 781 777 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 828 834 828 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 840 844 840 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5</italic>
###xml 854 862 854 862 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4</bold>
###xml 854 862 854 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g004"><bold>Figure 4</bold></xref>
Because of (i) their proximity to HLA-B*57, (ii) the previously reported dominant protective role of B*57 alleles in virologic control and disease progression, and (iii) the high degree of LD between the HLA-C5'-C, HLA-B*57 and HCP5-G alleles (Figure 1B and Figure 1C, top), we determined whether the effects attributable to the SNPs in HLA-C and HCP5 were in part due to these LD patterns and their presence within HLA-B*57-containing genotypes. To this end, we used strategies that were complementary to those we used to clarify the relationship between ZNRD1 and HLA-A10 alleles. We first evaluated the associations and distributions separately for the HLA-B*57, HLA-C5' and HCP5 alleles (Figure 3), and then because of their LD patterns, we determined the associations for B*57-containing genotypes that contained or lacked HLA-C5' and HCP5 alleles (Figure 4). We took this analytical approach of first analyzing the genotype-disease-influencing phenotypes at the level of the haplotype and then haplotype pairs (genotypes), as ultimately the phenotypic effect is conveyed by the genotype.
###end p 36
###begin title 37
###xml 48 65 48 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57, HLA-C5&#8242;</italic>
###xml 70 74 70 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5</italic>
###xml 86 89 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Disease-influencing effects associated with the HLA-B*57, HLA-C5' and HCP5 alleles in HIV-infected subjects from the WHMC cohort.
###end title 37
###begin p 38
###xml 269 277 269 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 302 308 302 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 329 333 329 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5</italic>
###xml 382 383 382 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 531 532 531 532 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 528 531 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
(A-C) Plots are Kaplan-Meier curves for time to AIDS (1987 criteria). Disease-influencing effects in all subjects (left column), and in the European American (middle column) and African American (right column) components of the WHMC cohort that are associated with (A) HLA-B*57 alleles, (B) the SNP in HLA-C5' and (C) the SNP in HCP5. RH, relative hazards; CI, confidence interval; P, significance value obtained by Cox proportional hazards modeling; n, number of subjects. (D) Distribution of the indicated alleles in the WHMC HIV+ cohort stratified according to time to AIDS or duration of AIDS-free status. These are indicated as time to AIDS in <2, 2 to <5, and >/=5 years, and no development of AIDS during the first 10 years or after 10 or more years of follow-up. For example, within each panel the left-most bar corresponds to subjects who developed AIDS within 2 years while the right-most bar indicates subjects who did not develop AIDS after 10 or more years of follow-up. At the bottom of each panel is shown significance value (obtained using chi-square test for linear trend) for a linear trend in the proportion of subjects possessing the indicated allele.
###end p 38
###begin title 39
###xml 44 64 44 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57/HCP5/HLA-C-</italic>
Disease-influencing effects associated with HLA-B*57/HCP5/HLA-C-containing genotypes.
###end title 39
###begin p 40
###xml 115 122 115 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*5</italic>
###xml 217 223 217 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C.</italic>
###xml 306 312 306 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5-G</italic>
###xml 612 616 612 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5</italic>
###xml 750 756 750 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5-G</italic>
###xml 765 766 765 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 821 840 821 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57/HCP5/HLA-C</italic>
###xml 895 899 895 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 978 982 978 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 1057 1065 1057 1065 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 1114 1115 1114 1115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1374 1385 1374 1385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCL3L1-CCR5</italic>
###xml 1653 1654 1648 1649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1738 1746 1733 1741 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 1844 1853 1839 1848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g002">Figure 2E</xref>
###xml 1879 1887 1874 1882 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 1895 1903 1890 1898 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 2477 2478 2468 2469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1630 1633 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
(A) Six genotypic groups (enumerated, color-coded) were derived by accounting first for the presence or absence of HLA-B*57 alleles and the wild-type (T/T), heterozygous (T/C) or homozygous (C/C) state for the SNP in HLA-C. This group of subjects was stratified further based on presence or absence of the HCP5-G allele. Number of subjects in each genotypic group is shown within the color-coded boxes. "+" and "-" denotes "presence" and "absence", respectively. (B) The disease-influencing effects associated with the six genotypic groups shown in panel A. (C) Kaplan-Meier plots depicting the influence of the HCP5 SNP on disease progression in subjects in genotypic group 2 stratified according to presence (group 2A) or absence (group 2B) of the HCP5-G allele. P values in panels B and C are by the logrank test. (D) HLA-B*57/HCP5/HLA-C genotypes that associate with nonprogressive disease (B*57-NPD, i.e., groups 1, 2B and 3 depicted in panels A-C) or progressive disease (B*57-PD; group 2A depicted in panel A and C) compared with genotypes that lack HLA-B*57. RH, relative hazards; CI, confidence interval; P, significance value obtained by Cox proportional hazards modeling; n, number of subjects. The RH was computed before (values above complete horizontal line) and after (below) adjustment for ethnic background, cohort membership across different therapy eras, CCL3L1-CCR5 genetic risk group status and whether date of seroconversion was known. All plots are Kaplan-Meier curves for time to AIDS development (1987 criteria). (E) Association of the genotypes shown in panel D with virologic and immunologic markers of HIV disease. daggerM-W P refers to significance values obtained by Mann-Whitney test for comparison between HLA-B*57-NPD genotype and the remaining cohort subjects. bCD4, nCD4, cCD4, VL and DTH are as described in Figure 2E. (F) The distribution of HLA-B*57-NPD or HLA-B*57-PD genotypes was examined according to time to AIDS or duration of AIDS-free status (left panel) as well as according to steady-state viral load (right panel). Data are from all subjects in the cohort. Time to AIDS or duration of AIDS-free status is shown on the bottom of the left panel and indicates time to AIDS in <2, 2 to <5, and >/=5 years, and no development of AIDS during the first 10 years or after 10 or more years of follow-up. Steady-state viral load shown on the right was categorized as <10,000, 10,000 to <20,000, 20,000 to <55,000 and >/=55,000 copies/ml. P value at the top of left panel is significance value for a linear trend obtained using chi-square test for linear trend.
###end p 40
###begin p 41
###xml 40 44 40 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 53 62 53 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3A</bold>
###xml 53 62 53 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g003"><bold>Figure 3A</bold></xref>
###xml 68 75 68 75 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 2</bold>
###xml 68 75 68 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003636-t002"><bold>Table 2</bold></xref>
###xml 131 137 131 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 138 140 138 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-C</italic>
###xml 149 158 149 158 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3B</bold>
###xml 149 158 149 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g003"><bold>Figure 3B</bold></xref>
###xml 163 170 163 170 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 2</bold>
###xml 163 170 163 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003636-t002"><bold>Table 2</bold></xref>
###xml 170 171 170 171 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">,</bold>
###xml 300 306 300 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 307 309 307 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-C</italic>
###xml 369 378 369 378 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3B</bold>
###xml 369 378 369 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g003"><bold>Figure 3B</bold></xref>
###xml 409 415 409 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5-G</italic>
###xml 576 585 576 585 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3C</bold>
###xml 576 585 576 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g003"><bold>Figure 3C</bold></xref>
###xml 590 597 590 597 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 2</bold>
###xml 590 597 590 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003636-t002"><bold>Table 2</bold></xref>
###xml 597 598 597 598 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">,</bold>
In univariate analyses, possession of a B*57 allele (Figure 3A, and Table 2, model 1), and heterozygosity and homozygosity for the HLA-C5'-C allele (Figure 3B and Table 2, model 2) were each associated with significant protective effects on the rate of disease progression to AIDS. The impact of the HLA-C5'-C allele on disease progression was greater in EAs than AAs (Figure 3B). In univariate analyses, the HCP5-G allele was associated with protective effects on disease progression, but this trend did not achieve statistical significance and was mostly restricted to EAs (Figure 3C and Table 2, model 3).
###end p 41
###begin title 42
###xml 46 54 46 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 60 66 60 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 72 76 72 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5</italic>
###xml 101 102 101 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 98 101 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Analysis of the disease-modulating effects of HLA-B*57, the HLA-C5' and HCP5 alleles/genotypes in HIV+ subjects from the WHMC cohort.
###end title 42
###begin p 43
###xml 183 185 183 185 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
Results are from univariate and multivariate Cox proportional hazards regression (for the outcome of time to AIDS (1987 criteria)) and linear regression models (for the outcome of log10 steady-state viral load) in all subjects from the WHMC cohort.
###end p 43
###begin p 44
RH, relative hazards; CI, confidence interval, Coeff, regression coefficient obtained from linear regression model.
###end p 44
###begin p 45
###xml 1 2 1 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 82 83 82 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
R2, the explained variability in steady-state viral loads was measured using the R2 estimated by analysis of variance (ANOVA).
###end p 45
###begin p 46
###xml 190 198 190 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 221 227 221 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*5701</italic>
###xml 236 245 236 245 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3D</bold>
###xml 236 245 236 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g003"><bold>Figure 3D</bold></xref>
###xml 377 383 377 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 384 386 384 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-C</italic>
###xml 395 404 395 404 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3D</bold>
###xml 395 404 395 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g003"><bold>Figure 3D</bold></xref>
###xml 472 473 472 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 579 587 579 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 589 599 589 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*5701</italic>
###xml 608 614 608 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 615 617 615 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-C</italic>
###xml 640 647 640 647 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 3</bold>
###xml 640 647 640 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003636-t003"><bold>Table 3</bold></xref>
###xml 733 739 733 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5-G</italic>
###xml 794 803 794 803 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3D</bold>
###xml 794 803 794 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g003"><bold>Figure 3D</bold></xref>
###xml 808 815 808 815 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 3</bold>
###xml 808 815 808 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003636-t003"><bold>Table 3</bold></xref>
###xml 887 893 887 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5-G</italic>
###xml 971 981 971 981 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*5701</italic>
###xml 991 1000 991 1000 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3D</bold>
###xml 991 1000 991 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g003"><bold>Figure 3D</bold></xref>
###xml 1054 1064 1054 1064 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*5701</italic>
###xml 1081 1087 1081 1087 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5-G</italic>
###xml 1132 1141 1132 1141 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1B</bold>
###xml 1132 1141 1132 1141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g001"><bold>Figure 1B</bold></xref>
###xml 469 472 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Consistent with the results of the univariate analyses, with increasing AIDS-free status, there was a statistically significant step-wise increase in the proportion of subjects possessing a HLA-B*57 allele, including the B*5701 allele (Figure 3D). A similar statistically significant trend for a shift in distribution with increasing AIDS-free status was also observed for the HLA-C5'-C allele (Figure 3D). Thus, compared to subjects who developed AIDS within 2 years, HIV+ subjects who were AIDS-free for more than 10 years were 12.7, 5.6 and 2.1 times more likely to possess a HLA-B*57, HLA-B*5701 and the HLA-C5'-C allele, respectively (Table 3). Increasing AIDS-free status was also associated with a trend for enrichment of the HCP5-G allele although this association was not significant (Figure 3D and Table 3). It was noteworthy that the degree of enrichment of subjects with the HCP5-G allele with increasing AIDS-free status was similar to that observed for the HLA-B*5701 subtype (Figure 3D). This observation is consistent with the LD between HLA-B*5701 subtype and the HCP5-G allele (D' = 0.91 for EAs and 0.73 for AAs, Figure 1B).
###end p 46
###begin title 47
###xml 78 81 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Likelihood of possessing specific alleles in subjects with different rates of HIV disease progression.
###end title 47
###begin p 48
###xml 98 101 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Results of multinomial logistic regression analyses and data are derived from all subjects in the HIV+ WHMC cohort.
###end p 48
###begin p 49
###xml 106 115 106 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g003">Figure 3D</xref>
Group 1 (progression to AIDS in less than two years) is the reference group, groups 1-5 are as defined in Figure 3D.
###end p 49
###begin p 50
###xml 61 67 61 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCL3L1</italic>
###xml 68 72 68 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 190 194 190 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Dolan1">[39]</xref>
Adjusted for seroconversion, race, and the moderate and high CCL3L1-CCR5 genetic risk groups (GRG), which in previous studies were identified as independent determinants of AIDS development [39].
###end p 50
###begin p 51
N, number of subjects.
###end p 51
###begin p 52
###xml 41 49 41 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 91 97 91 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 99 100 99 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 152 159 152 159 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 2</bold>
###xml 152 159 152 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003636-t002"><bold>Table 2</bold></xref>
###xml 159 160 159 160 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">,</bold>
###xml 266 272 266 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 273 275 273 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-C</italic>
###xml 361 368 361 368 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 2</bold>
###xml 361 368 361 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003636-t002"><bold>Table 2</bold></xref>
###xml 368 369 368 369 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">,</bold>
###xml 440 446 440 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 447 449 447 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-C</italic>
###xml 629 636 629 636 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 2</bold>
###xml 629 636 629 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003636-t002"><bold>Table 2</bold></xref>
###xml 700 708 700 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 772 778 772 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 780 781 780 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 833 841 833 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
When placed in a multivariate model with HLA-B*57, heterozygosity and homozygosity for the HLA-C5'-C independently associated with disease-retardation (Table 2, compare models 2 and 4). However, the statistical significance of the protective effects associated with HLA-C5'-C in multivariate models were slightly lower than those observed in univariate models (Table 2, compare models 2 and 4). This was most prominent for homozygosity for HLA-C5'-C as the hazard ratios for the rate of progression to AIDS were 0.66 (P = 0.025) and 0.72 (P = 0.067) in univariate and multivariate analyses, respectively (compare models 2 and 4, Table 2). These results indicated that possibly because of its LD with HLA-B*57, the strength of the disease-retarding effects associated with HLA-C5'-C may in part be due to the effects conferred by the HLA-B*57 allele.
###end p 52
###begin p 53
###xml 105 111 105 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5-G</italic>
###xml 158 159 158 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 243 250 243 250 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 2</bold>
###xml 243 250 243 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003636-t002"><bold>Table 2</bold></xref>
###xml 329 333 329 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 360 364 360 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5</italic>
###xml 411 412 411 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 422 429 422 429 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 2</bold>
###xml 422 429 422 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003636-t002"><bold>Table 2</bold></xref>
###xml 550 554 550 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 572 573 572 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 584 591 584 591 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 2</bold>
###xml 584 591 584 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003636-t002"><bold>Table 2</bold></xref>
###xml 591 592 591 592 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">,</bold>
###xml 669 675 669 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5-G</italic>
###xml 763 764 763 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 774 781 774 781 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 2</bold>
###xml 774 781 774 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003636-t002"><bold>Table 2</bold></xref>
###xml 781 782 781 782 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">,</bold>
###xml 798 804 798 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 805 807 805 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-C</italic>
###xml 883 890 883 890 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 2</bold>
###xml 883 890 883 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003636-t002"><bold>Table 2</bold></xref>
###xml 986 992 986 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5-G</italic>
###xml 997 1001 997 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 1081 1088 1081 1088 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 2</bold>
###xml 1081 1088 1081 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003636-t002"><bold>Table 2</bold></xref>
###xml 1088 1089 1088 1089 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">,</bold>
In univariate analysis, the hazard ratio for the rate of disease progression to AIDS associated with the HCP5-G allele was <1 (RH = 0.67, 95% CI = 0.39-1.14, P = 0.135), suggesting that this allele might convey weak disease-retarding effects (Table 2, model 3). However, when examined in the context of a multivariate model with B*57, the hazard ratio for the HCP5 allele was >1 (RH = 2.06; 95% CI = 0.98-4.33, P = 0.056; Table 2, model 5). Conversely, in the univariate analyses, the hazard ratio for rate of disease progression associated with the B*57 allele was 0.38 (P = 0.0002, Table 2, model 1), whereas when examined in the context of a multivariate model with HCP5-G, the hazard ratio was lower (RH = 0.25) and the strength of the association increased (P = 0.0001 Table 2, model 5). When HLA-C5'-C heterozygosity and homozygosity were also added to the multivariate model (Table 2, model 6), the strength of the observed detrimental and beneficial effects associated with the HCP5-G and B*57 alleles, respectively, on disease progression became even further accentuated (Table 2, compare models 5 and 6).
###end p 53
###begin p 54
###xml 95 101 95 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5-G</italic>
###xml 264 268 264 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 393 397 393 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 402 408 402 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5-G</italic>
###xml 492 496 492 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 533 539 533 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5-T</italic>
###xml 624 628 624 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 671 677 671 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5-G</italic>
###xml 730 736 730 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*</italic>
###xml 737 738 737 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</italic>
###xml 841 852 841 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57/HCP5-G</italic>
###xml 932 936 932 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 1043 1049 1043 1049 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 1050 1061 1050 1061 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;HLA-B&#8211;HCP5</italic>
###xml 1082 1091 1082 1091 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1C</bold>
###xml 1082 1091 1082 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g001"><bold>Figure 1C</bold></xref>
###xml 1127 1136 1127 1136 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure S3</bold>
###xml 1127 1136 1127 1136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003636.s004"><bold>Figure S3</bold></xref>
We inferred that the opposing direction of the disease-influencing effects associated with the HCP5-G allele in the univariate (RH<1, protective effects) and multivariate (RH >1, detrimental effects) analyses, and the accentuation of the protective effects of the B*57 in the multivariate models, convey the following: when examined at the haplotype level, those haplotypes which contain both B*57 and HCP5-G alleles are associated with a faster rate of disease progression compared to those B*57-containing haplotypes that bear the HCP5-T allele. Consequently, in multivariate models when the overall beneficial effects of B*57 are partitioned out or accounted for, the HCP5-G allele, which is in nearly 100% LD with a subset of HLA-B*57 alleles, associates with disease-acceleration. Conversely, in multivariate models when the effects of B*57/HCP5-G haplotypes are partitioned out, the overall beneficial effects associated with B*57 are accentuated. Concordant results (and inferences) were obtained when we studied the association of the HLA-C5'-HLA-B-HCP5 haplotypes shown in Figure 1C with rates of disease progression (Figure S3).
###end p 54
###begin title 55
Influence of HLA-C and HCP5 on viral load
###end title 55
###begin p 56
###xml 97 105 97 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 107 111 107 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5</italic>
###xml 116 122 116 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 309 313 309 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 315 320 315 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
###xml 325 329 325 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5</italic>
###xml 410 411 410 411 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 421 422 421 422 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 468 475 468 475 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 2</bold>
###xml 468 475 468 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003636-t002"><bold>Table 2</bold></xref>
###xml 482 486 482 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 503 508 503 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
###xml 526 530 526 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5</italic>
###xml 648 653 648 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
###xml 658 662 658 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5</italic>
###xml 756 760 756 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 831 835 831 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Fellay1">[27]</xref>
###xml 407 410 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
We next examined whether the direction and the relative strength of the effects observed for the HLA-B*57, HCP5 and HLA-C5' alleles on rates of disease progression are similar to those observed when the steady-state viral load is used as a phenotypic endpoint. The hierarchal order of the extent to which the B*57, HLA-C and HCP5 alleles explained the variability in the steady-state viral load in the WHMC HIV+ cohort (R2 estimates as percentages are in parenthesis; Table 2) was: B*57 (3.2%; model 1)>HLA-C (0.72%; model 2)>HCP5 (0.38%; model 3). These findings indicated that at least within the context of a natural history cohort, the SNPs in HLA-C and HCP5 explained only one-third to one-tenth of the variability in steady-state viral load than the B*57 allele, and several fold less than the reported estimates in the GWAS [27].
###end p 56
###begin p 57
###xml 314 322 314 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 393 399 393 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 400 402 400 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-C</italic>
###xml 423 429 423 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5-G</italic>
###xml 559 566 559 566 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 559 566 559 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003636-t001"><bold>Table 1</bold></xref>
###xml 566 567 566 567 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">,</bold>
###xml 658 664 658 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5-G</italic>
###xml 715 716 715 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 725 732 725 732 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 725 732 725 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003636-t001"><bold>Table 1</bold></xref>
###xml 732 733 732 733 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">,</bold>
###xml 820 824 820 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 846 847 846 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 857 864 857 864 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 857 864 857 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003636-t001"><bold>Table 1</bold></xref>
###xml 864 865 864 865 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">,</bold>
###xml 888 892 888 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 904 910 904 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 946 947 946 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 957 964 957 964 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 957 964 957 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003636-t001"><bold>Table 1</bold></xref>
###xml 964 965 964 965 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">,</bold>
###xml 1050 1056 1050 1056 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5-G</italic>
###xml 1142 1149 1142 1149 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 1142 1149 1142 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003636-t001"><bold>Table 1</bold></xref>
###xml 1243 1250 1243 1250 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 1243 1250 1243 1250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003636-t001"><bold>Table 1</bold></xref>
###xml 1389 1395 1389 1395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5-G</italic>
###xml 1503 1511 1503 1511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 1515 1521 1515 1521 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 1522 1524 1522 1524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-C</italic>
###xml 1550 1556 1550 1556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5-G</italic>
###xml 1734 1735 1734 1735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1745 1752 1745 1752 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 1745 1752 1745 1752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003636-t001"><bold>Table 1</bold></xref>
To further evaluate the influence of these alleles on viral load, univariate and multivariate linear regression analyses were conducted in which these alleles were considered as independent variables and the steady-state viral load was considered as the dependent variable. Univariate analysis revealed that (i) a HLA-B*57 allele, (ii) one (heterozygosity) or two (homozygosity) copies of the HLA-C5'-C allele, and (iii) a HCP5-G allele each associated with a lower steady-state viral load (as reflected by the negative values of the regression coefficients; Table 1, models 1 to 3). However, the viral load-mitigating effects observed for possession of the HCP5-G allele in the univariate analysis (Coeff = -0.25; P = 0.03, Table 1, model 3) was not evident when this allele was examined in a multivariate context with B*57 alone (Coeff = 0.46; P = 0.005, Table 1, model 5), or with the B*57 allele and HLA-C5' genotypes together (Coeff = 0.56; P = 0.001, Table 1, model 6). Thus, the opposing direction of the viral load-influencing effects of the HCP5-G allele observed in the univariate (negative value for the regression coefficients in Table 1, model 3; Coeff = -0.25) and multivariate (positive value for the regression coefficients in Table 1, models 5 (Coeff = 0.46) and 6 (Coeff = 0.56)) analyses closely mirrored the opposing direction of the disease-influencing effects of the HCP5-G allele observed in univariate and multivariate analyses. Thus, once the protective effects associated with HLA-B*57 or HLA-C5'-C are partitioned out, the HCP5-G allele associated with not only a faster rate of disease progression (RH = 2.19; 95% CI = 1.07-4.46; P = 0.032), but also a higher viral load (Coeff = 0.56; 95% CI = 0.23-0.88; P = 0.001; Table 1, model 6).
###end p 57
###begin p 58
###xml 75 83 75 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 85 91 85 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 97 101 97 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5</italic>
###xml 200 201 200 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 211 212 211 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 237 244 237 244 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 2</bold>
###xml 237 244 237 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003636-t002"><bold>Table 2</bold></xref>
###xml 292 300 292 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 382 388 382 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 432 439 432 439 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 2</bold>
###xml 432 439 432 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003636-t002"><bold>Table 2</bold></xref>
###xml 444 448 444 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 475 481 475 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 543 549 543 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 550 552 550 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-C</italic>
###xml 197 200 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Analyses of the final multivariate regression model also revealed that the HLA-B*57, HLA-C5' and HCP5 alleles together explained 4.66% of the variability in the steady-state viral load in the WHMC HIV+ cohort (R2 estimate for model 6 in Table 2). Additionally, the final model indicates that HLA-B*57 alleles might confer a greater protective effect on early viral replication than HLA-C5' alleles (Coefficient values in model 6 in Table 2 for B*57 was -0.82, whereas it was HLA-C5' -0.08 and -0.26 for heterozygosity and homozygosity for the HLA-C5'-C allele).
###end p 58
###begin title 59
Effects of B*57-, HLA-C- and HCP5-containing genotypes
###end title 59
###begin p 60
###xml 86 90 86 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 97 106 97 106 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2A</bold>
###xml 97 106 97 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g002"><bold>Figure 2A</bold></xref>
###xml 239 244 239 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
###xml 249 255 249 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5-G</italic>
###xml 294 302 294 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 304 310 304 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5-G</italic>
###xml 315 321 315 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 322 324 322 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-C</italic>
###xml 334 343 334 343 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1B</bold>
###xml 334 343 334 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g001"><bold>Figure 1B</bold></xref>
###xml 348 357 348 357 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1C</bold>
###xml 348 357 348 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g001"><bold>Figure 1C</bold></xref>
###xml 510 514 510 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 599 603 599 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 690 696 690 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5-G</italic>
###xml 704 710 704 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 711 713 711 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-C</italic>
###xml 858 864 858 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 865 867 865 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-C</italic>
###xml 901 905 901 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 1069 1073 1069 1073 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5</italic>
###xml 1078 1083 1078 1083 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
###xml 1132 1136 1132 1136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 1145 1154 1145 1154 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4A</bold>
###xml 1145 1154 1145 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g004"><bold>Figure 4A</bold></xref>
The aforementioned findings indicated that the 'protective' phenotype attributable to B*57 (e.g. Figure 2A) is a composite, i.e., an overall phenotype that is evident before accounting for the independent phenotypic effects of the SNPs in HLA-C and HCP5-G. Based on the LD patterns between the HLA-B*57, HCP5-G and HLA-C5'-C alleles (Figure 1B and Figure 1C, top) and associations described above for each of these alleles, we surmised that a more accurate assessment of the phenotypic effects attributable to B*57 alleles might be attained by evaluation of the genotype-phenotype relationships for B*57-containing genotypes that are defined based on whether or not they also contained the HCP5-G and/or HLA-C5'-C alleles. Conversely, such an approach we surmised would also provide insights into the extent to which the protective effects attributed to the HLA-C5'-C allele is due to its presence in B*57-containing genotypes. To investigate this, we categorized subjects into six genotypic groups which permitted an analysis of the phenotypic effects associated with HCP5 and HLA-C alleles in genotypes that contained or lacked a B*57 allele (Figure 4A).
###end p 60
###begin p 61
###xml 123 124 111 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 183 192 171 180 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4B</bold>
###xml 183 192 171 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g004"><bold>Figure 4B</bold></xref>
These six genotypic groups together explained approximately3.1% of variability in steady-state viral load (as analyzed by R2) and conferred differential rates of disease progression (Figure 4B). Examination of the survival curves for these six genotypic groups revealed the following genotype-phenotype relationships.
###end p 61
###begin p 62
###xml 19 23 19 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 73 82 73 82 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4A</bold>
###xml 73 82 73 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g004"><bold>Figure 4A</bold></xref>
###xml 118 122 118 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 156 162 156 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 281 290 281 290 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4B</bold>
###xml 281 290 281 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g004"><bold>Figure 4B</bold></xref>
###xml 345 349 345 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 415 421 415 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 422 424 422 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-C</italic>
###xml 477 486 477 486 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4B</bold>
###xml 477 486 477 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g004"><bold>Figure 4B</bold></xref>
###xml 557 561 557 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 618 624 618 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 625 627 625 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-C</italic>
###xml 748 757 748 757 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3B</bold>
###xml 748 757 748 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g003"><bold>Figure 3B</bold></xref>
###xml 828 834 828 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 835 837 835 837 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-C</italic>
###xml 915 923 915 923 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 848 851 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Subjects lacking a B*57 allele were assigned to genotypic groups 4 to 6 (Figure 4A). Predictably, as group 4 lacked a B*57 allele as well as the protective HLA-C5' allele, subjects within this group displayed the fastest rate of disease progression among the six genotypic groups (Figure 4B). It was noteworthy that in those subjects who lacked B*57, but were heterozygous (group 5) or homozygous (group 6) for the HLA-C5'-C allele had comparable rates of disease progression (Figure 4B). This contrasted with the observation that when LD patterns with the B*57 allele had not been accounted for, homozygosity for the HLA-C5'-C allele was associated with a greater protective effect against disease progression than heterozygosity for this allele (Figure 3B). The latter finding indicated that the maximal protective effects of HLA-C5'-C allele on HIV disease course might be evident when this allele is present in HLA-B*57-containing genotypes, and the data presented below affirm this possibility.
###end p 62
###begin p 63
###xml 16 20 16 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 95 99 95 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 193 202 193 202 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4B</bold>
###xml 193 202 193 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g004"><bold>Figure 4B</bold></xref>
###xml 322 331 322 331 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4B</bold>
###xml 322 331 322 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g004"><bold>Figure 4B</bold></xref>
###xml 358 364 358 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5-G</italic>
###xml 528 534 528 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5-G</italic>
###xml 557 566 557 566 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4A</bold>
###xml 557 566 557 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g004"><bold>Figure 4A</bold></xref>
###xml 649 658 649 658 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4C</bold>
###xml 649 658 649 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g004"><bold>Figure 4C</bold></xref>
###xml 706 714 706 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 721 727 721 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 728 730 728 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-C</italic>
###xml 751 757 751 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5-G</italic>
###xml 766 775 766 775 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4A</bold>
###xml 766 775 766 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g004"><bold>Figure 4A</bold></xref>
###xml 795 801 795 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5-G</italic>
###xml 871 880 871 880 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4C</bold>
###xml 871 880 871 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g004"><bold>Figure 4C</bold></xref>
###xml 993 999 993 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5-G</italic>
###xml 1106 1114 1106 1114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 1119 1125 1119 1125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 1126 1128 1126 1128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-C</italic>
###xml 1224 1232 1224 1232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 1237 1242 1237 1242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5G</italic>
###xml 1325 1331 1325 1331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5-G</italic>
###xml 1409 1416 1409 1416 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 2</bold>
###xml 1409 1416 1409 1416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003636-t002"><bold>Table 2</bold></xref>
Subjects with a B*57 allele were assigned to genotypic groups 1 to 3, but despite containing a B*57 allele, these genotypic groups were associated with contrasting disease-influencing effects (Figure 4B). Compared to subjects assigned to genotypic groups 1 or 3, those in group 2 had a faster rate of disease progression (Figure 4B). The distribution of the HCP5-G allele in group 2 revealed that individuals assigned to this group could be stratified into two broad categories, with subgroups 2A and 2B possessing or lacking a HCP5-G allele, respectively (Figure 4A). Remarkably, none of the 10 subjects categorized to group 2B progressed to AIDS (Figure 4C), and they all had a genotype that contained a HLA-B*57 and a HLA-C5'-C allele but lacked a HCP5-G allele (Figure 4A). By contrast, the HCP5-G-carrying subjects categorized to group 2A had a progressive disease (Figure 4C). The differential disease outcomes associated with groups 2A and 2B indicated that genotypes which contained a HCP5-G allele associated with disease acceleration despite containing two separate 'protective' alleles namely a HLA-B*57 and HLA-C5'-C allele (group 2A). Thus, the genotype-phenotype relationship for group 2A (which contains both HLA-B*57 and HCP5G alleles) may explain why when examined in a multivariate model, possession of the HCP5-G allele was associated with both disease acceleration and higher viral loads (Table 2, model 6).
###end p 63
###begin p 64
###xml 64 73 64 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4B</bold>
###xml 64 73 64 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g004"><bold>Figure 4B</bold></xref>
###xml 111 117 111 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 118 120 118 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-C</italic>
###xml 135 139 135 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 196 205 196 205 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4B</bold>
###xml 196 205 196 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g004"><bold>Figure 4B</bold></xref>
###xml 288 294 288 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5-G</italic>
###xml 335 339 335 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 394 400 394 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5-G</italic>
###xml 471 477 471 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 478 480 478 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-C</italic>
###xml 490 499 490 499 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4B</bold>
###xml 490 499 490 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g004"><bold>Figure 4B</bold></xref>
###xml 552 556 552 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Gonzalez1">[34]</xref>
###xml 558 562 558 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Mangano1">[41]</xref>
The phenotype of subjects in group 3 was also very instructive (Figure 4B). These subjects were homozygous for HLA-C5'-C and possessed B*57 and had among the slowest rates of disease progression (Figure 4B). This occurred despite the fact that most subjects in group 3 also possessed the HCP5-G allele. Thus, among those who possessed B*57, the disease-accelerating effects associated with the HCP5-G allele was evident in those with one (group 2A) but not two (group 3) HLA-C5'-C alleles (Figure 4B). These observations underscore our previous thesis [34], [41] that analyses conducted at the allele level obscure complex genotype-phenotype relationships that occur when the phenotypic effects of both haplotypes are accounted for.
###end p 64
###begin p 65
###xml 65 73 65 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 142 147 142 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
###xml 282 286 282 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 321 327 321 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 328 330 328 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-T</italic>
###xml 439 445 439 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 446 448 446 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-C</italic>
###xml 492 500 492 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 585 589 585 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 686 691 686 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57-</italic>
###xml 725 733 725 733 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4</bold>
###xml 725 733 725 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g004"><bold>Figure 4</bold></xref>
###xml 733 736 733 736 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">, B</bold>
###xml 741 742 741 742 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
These survival curves also underscore two other points: First, a HLA-B*57-containing genotype does not require the presence of a 'protective' HLA-C allele to convey a protective effect on disease progression. This is reflected by the observation that subjects in group 1 who have a B*57 allele and are homozygous for the HLA-C5'-T allele have a slow disease course. Second, the maximal 'protective' effects associated with possession of a HLA-C5'-C allele occurs only when it is present in a HLA-B*57-containing genotype. This is reflected by the observation that subjects assigned to B*57-containing genotypic groups 2B or 3 have a much slower disease course than those categorized to B*57-lacking genotypic groups 5 and 6 (Figure 4, B and C, compare survival curves for groups 2B and 3 vs those for groups 5 and 6).
###end p 65
###begin title 66
B*57-containing genotypes and progressive disease
###end title 66
###begin p 67
###xml 122 126 122 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 161 165 161 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Migueles2">[20]</xref>
###xml 167 171 167 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Navis1">[22]</xref>
###xml 173 177 173 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Bailey1">[42]</xref>
###xml 242 251 242 251 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4B</bold>
###xml 242 251 242 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g004"><bold>Figure 4B</bold></xref>
###xml 256 265 256 265 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4C</bold>
###xml 256 265 256 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g004"><bold>Figure 4C</bold></xref>
###xml 327 335 327 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
There is clinical, virologic and immunologic data indicating a conundrum: some subjects despite possessing a 'protective' B*57 have a progressive disease course [20], [22], [42]. We surmised that the genotype-phenotype relationships shown in Figure 4B and Figure 4C might address this paradox as they showed that subjects with HLA-B*57-containing genotypes classify into two categories.
###end p 67
###begin p 68
###xml 182 190 182 190 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4</bold>
###xml 182 190 182 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g004"><bold>Figure 4</bold></xref>
###xml 190 199 190 199 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">, B and C</bold>
###xml 258 262 258 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 280 289 280 289 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4D</bold>
###xml 280 289 280 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g004"><bold>Figure 4D</bold></xref>
###xml 314 318 314 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 425 429 425 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 469 470 469 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 479 481 479 481 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 483 492 483 492 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4D</bold>
###xml 483 504 483 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g004"><bold>Figure 4D</bold>, left panel</xref>
###xml 570 579 570 579 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4D</bold>
###xml 570 591 570 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g004"><bold>Figure 4D</bold>, left panel</xref>
###xml 720 724 720 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Dolan1">[39]</xref>
###xml 726 730 726 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-He1">[43]</xref>
The first group are those subjects with genetic features present in genotypic groups 1, 2B or 3 as these genotypic groups are associated with a non-progressive disease (NPD) course (Figure 4, B and C), and collectively these genotypes are designated here as B*57-NPD genotypes in Figure 4D. In the overall cohort, B*57-NPD genotypes conferred a nearly 83% slower rate of disease progression compared to genotypes that lack a B*57 allele (RH = 0.17, 95% CI = 0.07-0.41, P = 7.2x10-5; Figure 4D, left panel). These associations detected at the level of the entire cohort (Figure 4D, left panel) remained consistent after adjustment for covariates known to influence disease progression in this cohort, including ethnicity [39], [43].
###end p 68
###begin p 69
###xml 88 92 88 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 215 219 215 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 235 244 235 244 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4D</bold>
###xml 235 244 235 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g004"><bold>Figure 4D</bold></xref>
###xml 294 301 294 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57-PD</italic>
###xml 342 346 342 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 355 364 355 364 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4D</bold>
###xml 355 364 355 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g004"><bold>Figure 4D</bold></xref>
###xml 483 484 483 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 540 549 540 549 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4D</bold>
###xml 540 549 540 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g004"><bold>Figure 4D</bold></xref>
###xml 549 550 549 550 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">;</bold>
###xml 652 661 652 661 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure S4</bold>
###xml 652 661 652 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003636.s005"><bold>Figure S4</bold></xref>
###xml 716 724 716 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57-NPD</italic>
###xml 816 820 816 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 860 861 860 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 480 483 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The second group are those subjects categorized to group 2A and, compared to those with B*57-NPD genotypes, the clinical course of subjects in this group is characterized by a progressive disease (PD; designated as B*57-PD genotype in Figure 4D). Remarkably, the disease course of those with a B*57-PD genotype is similar to those who lack a B*57 allele (Figure 4D). Consistent genotype-phenotype relationships were also evident when similar analyses were conducted separately in HIV+ EAs and AAs before and after adjusting for covariates (Figure 4D; middle and right panels) or when the analyses were restricted to subjects who did not receive HAART (Figure S4). In these HAART-free subjects, those assigned to the B*57-NPD genotypic group had a nearly 80% lower risk of progressing to AIDS than those who lacked a B*57 allele (RH = 0.21; 95% CI = 0.08-0.57; P = 0.002).
###end p 69
###begin p 70
###xml 92 93 92 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 238 242 238 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 248 252 248 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 276 280 276 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 412 413 412 413 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 477 481 477 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 487 491 487 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 513 517 513 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 519 528 519 528 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4E</bold>
###xml 519 528 519 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g004"><bold>Figure 4E</bold></xref>
###xml 570 574 570 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 580 584 580 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 606 610 606 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 674 683 674 683 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4E</bold>
###xml 674 683 674 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g004"><bold>Figure 4E</bold></xref>
###xml 751 752 751 752 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 791 795 791 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 804 808 804 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 896 900 896 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 909 918 909 918 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4E</bold>
###xml 909 918 909 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g004"><bold>Figure 4E</bold></xref>
Based on the aforementioned findings we surmised that the comparison of the immunologic (CD4+ T cell profiles and DTH skin test reactivity) and virologic (viral load) profiles would reveal a step-wise worsening in subjects categorized to B*57-NPD, B*57-PD and those lacking a B*57 allele. In general agreement with this, as a general rule, there was a step-wise decrease in the baseline, cumulative and nadir CD4+ T cell counts as well as DTH responses in subjects assigned to B*57-NPD, B*57-PD and those lacking B*57 (Figure 4E). Conversely, in subjects categorized to B*57-NPD, B*57-PD and those lacking B*57 there was a step-wise increase in the steady-state viral load (Figure 4E). The only exception to this general rule was that the baseline CD4+ T cell counts in subjects assigned to B*57-NPD and B*57-PD were similar, but they were higher than the cell counts found in those who lacked a B*57 allele (Figure 4E).
###end p 70
###begin p 71
###xml 17 21 17 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 422 426 422 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 448 457 448 457 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3D</bold>
###xml 448 457 448 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g003"><bold>Figure 3D</bold></xref>
###xml 509 513 509 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 541 545 541 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 558 565 558 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57-PD</italic>
###xml 662 671 662 671 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4F</bold>
###xml 662 671 662 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g004"><bold>Figure 4F</bold></xref>
###xml 848 852 848 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 942 946 930 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 961 970 949 958 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4F</bold>
###xml 961 982 949 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g004"><bold>Figure 4F</bold>, left panel</xref>
###xml 1003 1012 991 1000 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4F</bold>
###xml 1003 1012 991 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g004"><bold>Figure 4F</bold></xref>
###xml 1202 1207 1190 1195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57-</italic>
###xml 1279 1283 1267 1271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 1387 1396 1373 1382 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4F</bold>
###xml 1387 1396 1373 1382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g004"><bold>Figure 4F</bold></xref>
###xml 1434 1443 1420 1429 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4F</bold>
###xml 1434 1443 1420 1429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g004"><bold>Figure 4F</bold></xref>
###xml 1499 1503 1485 1489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 1530 1534 1516 1520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 1543 1547 1529 1533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 1617 1621 1603 1607 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 99 102 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 764 767 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
To validate that B*57-containing NPD and PD genotypes convey contrasting phenotypic effects during HIV disease course we used a complementary approach and determined the distributions of these genotypes as a function of increasing AIDS-free status and steady-state viral loads with the intent of testing two premises. First, although increasing AIDS-free status is associated with a stepwise enrichment of subjects with a B*57-containing genotype (Figure 3D), the greatest enrichment should be for those with B*57-NPD genotypes. Second, the B*57-NPD and not B*57-PD genotypes should be enriched for subjects with a low steady-state viral load. The data shown in Figure 4F (left panel) provides evidence in support for the first premise. Nearly 12 percent of those HIV-positive individuals who were AIDS-free after 10 years of follow-up possessed a B*57-containing genotype, and strikingly approximately90% of these subjects were those with a B*57-NPD genotype (Figure 4F, left panel). The data shown in Figure 4F (right panel) provides evidence in support of the second premise as among subjects with a steady-state viral load lower than 10,000 copies/ml, there was an overrepresentation of those with B*57-NPD genotypes. It was noteworthy that the proportion of subjects with a B*57-PD genotype was similar in those who had a steady-state viral load of <10,000 and >/=55,000 copies/ml (Figure 4F). Thus, these distribution patterns (Figure 4F) provide additional validity for the categorization of B*57-containing genotypes into B*57-NPD and B*57-PD genotypes as a means to improve the accuracy of identifying those B*57-carrying subjects who may have a slower disease course or control of viral replication during the early phases of infection.
###end p 71
###begin title 72
Viral load-independent effects of B*57-NPD genotypes
###end title 72
###begin p 73
###xml 104 108 104 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Mellors1">[28]</xref>
###xml 110 114 110 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Mellors2">[29]</xref>
###xml 184 188 184 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 490 494 478 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Dolan1">[39]</xref>
###xml 635 636 623 624 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 675 679 663 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Rodriguez1">[44]</xref>
###xml 681 685 669 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Henry1">[45]</xref>
###xml 883 890 871 878 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 4</bold>
###xml 883 890 871 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003636-t004"><bold>Table 4</bold></xref>
###xml 910 918 898 906 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
Based on the well-established, strong relationship between steady-state viral load and AIDS development [28], [29], one interpretation of the aforementioned findings might be that the B*57-NPD genotypes convey disease-retardation by simply influencing the extent of early viral replication. However, in a recent study, we found that although the steady-state viral load is a strong predictor of AIDS risk, it accounted for only approximately12% of the variability in AIDS progression rates [39]. The findings by Rodriguez et al also suggest that the contribution of viral load to the explained variability in the rate of decline in CD4+ T cell counts might not be very large [44], [45]. These data indicated that parameters that are independent of viral load are also critical determinants of AIDS pathogenesis. We therefore used nested multivariate Cox proportional hazards models (Table 4) to assess whether HLA-B*57-NPD genotypes affected disease progression independent of the viral load.
###end p 73
###begin title 74
###xml 54 62 54 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
Viral load-independent disease-influencing effects of HLA-B*57-containing genotypes.
###end title 74
###begin p 75
###xml 143 144 143 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 142 146 142 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B<sup>*</sup>57</italic>
###xml 155 156 155 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 154 158 154 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B<sup>*</sup>57</italic>
###xml 340 341 340 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 415 416 415 416 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 414 418 414 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B<sup>*</sup>57</italic>
###xml 473 474 473 474 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 472 476 472 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B<sup>*</sup>57</italic>
###xml 513 514 513 514 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 512 516 512 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B<sup>*</sup>57</italic>
###xml 587 588 587 588 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 586 590 586 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B<sup>*</sup>57</italic>
###xml 628 629 628 629 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 627 631 627 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B<sup>*</sup>57</italic>
###xml 710 719 710 719 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4D</bold>
###xml 710 719 710 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g004"><bold>Figure 4D</bold></xref>
Results are from nested multivariate Cox proportional hazards models for the outcome of time to AIDS (1987 criteria) for subjects assigned to B*57-PD and B*57-NPD before (none, model 1) and after adjustment for covariates individually (models 2 to 6) or in unison (models 7 to 10). Data is presented as relative hazard (RH) with 95% CI and P values. The reference group for all the comparisons is those who lack a B*57 allele (relative hazard = 1). N, number of subjects. B*57-PD represents subjects who possess B*57-containing genotypes that associate with progressive disease whereas B*57-NPD represents subjects who possess B*57-containing genotypes that associate with non-progressive disease (as shown in Figure 4D).
###end p 75
###begin p 76
###xml 87 95 87 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57-NPD</italic>
###xml 191 199 179 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 239 246 227 234 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 4</bold>
###xml 239 246 227 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003636-t004"><bold>Table 4</bold></xref>
###xml 484 488 472 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 581 588 569 576 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 4</bold>
###xml 581 588 569 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003636-t004"><bold>Table 4</bold></xref>
###xml 680 687 668 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57-PD</italic>
###xml 708 712 696 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 754 761 742 749 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 4</bold>
###xml 754 761 742 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003636-t004"><bold>Table 4</bold></xref>
###xml 857 864 845 852 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 4</bold>
###xml 857 864 845 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003636-t004"><bold>Table 4</bold></xref>
###xml 51 54 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 64 71 <span type="species:ncbi:9606">persons</span>
Before accounting for any of the covariates, those HIV-positive persons categorized to B*57-NPD had an approximately83% lower risk of progressing to AIDS compared to individuals who lacked a HLA-B*57 allele (RH = 0.17; 95% CI = 0.07-0.41; Table 4, model 1). We next adjusted-individually and in unison-for the disease-influencing effects of several explanatory variables. These analyses revealed that even after adjustment for the disease-influencing effects of these covariates, the B*57-NPD genotypes remained strong independent predictors of a slow rate of disease progression (Table 4, models 2 to 10). By contrast, the rates of disease progression among those categorized to B*57-PD and those lacking a B*57 allele were not statistically different (Table 4, model 1), and this association remained after inclusion of the other covariates in the model (Table 4, models 2 to 10).
###end p 76
###begin title 77
Discussion
###end title 77
###begin p 78
###xml 187 192 187 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1</italic>
###xml 292 299 292 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 359 365 359 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 442 447 442 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
###xml 452 456 452 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 513 518 513 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
###xml 576 585 576 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57-</italic>
###xml 626 632 626 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5-G</italic>
###xml 670 676 670 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*5701</italic>
###xml 758 762 758 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 767 773 767 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5-G</italic>
###xml 801 807 801 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*5701</italic>
###xml 849 855 849 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5-G</italic>
###xml 899 905 899 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 906 908 906 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-C</italic>
###xml 933 939 933 939 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 940 942 940 942 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-C</italic>
###xml 1026 1032 1026 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 1033 1035 1033 1035 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-C</italic>
###xml 1065 1071 1065 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 1072 1074 1072 1074 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-C</italic>
###xml 1171 1175 1171 1175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 1181 1187 1181 1187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5-G</italic>
###xml 1295 1301 1295 1301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5-G</italic>
###xml 1362 1366 1362 1366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 1383 1388 1383 1388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1</italic>
###xml 1488 1493 1488 1493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
###xml 1553 1561 1553 1561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 1653 1658 1653 1658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
###xml 1682 1690 1682 1690 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 1745 1749 1745 1749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Fellay1">[27]</xref>
###xml 1839 1843 1839 1843 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 2056 2060 2056 2060 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 2092 2096 2092 2096 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 98 103 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The salient genetic-epidemiologic findings of this study conducted in a natural history cohort of HIV-1 subjects are as follows. First, because of their LD patterns, the associations for ZNRD1 alleles were evident only when these alleles were also present with alleles that categorize to the HLA-A10 serogroup. Second, heterozygosity and homozygosity for the HLA-C5' allele were associated with disease retardation, but because of LD between HLA-C and B*57 alleles, the maximal beneficial effects associated with HLA-C-bearing genotypes were evident when they were present in HLA-B*57-containing genotypes. Third, because the HCP5-G allele is in nearly 100% LD with the B*5701 allele, the genotype-phenotype relationships observed for genotypes that contain B*57 and HCP5-G alleles reflected those of B*5701-containing genotypes. We find that those HCP5-G-carrrying individuals who have one copy of HLA-C5'-C (i.e., heterozygous for HLA-C5'-C) had a progressive disease course whereas most of those who bear two copies of the HLA-C5'-C allele (i.e., homozygous for HLA-C5'-C) have a nonprogressive disease course. Fourth, after partitioning out the protective effects of B*57, the HCP5-G allele was associated with disease-acceleration and enhanced viral replication, and these associations for HCP5-G were otherwise masked because of its LD with the protective B*57 alleles. Fifth, ZNRD1 alleles influenced disease course without impacting on the viral load. Sixth, the influence of the HLA-C on the steady-state viral load was much lower than that of HLA-B*57 alleles, and the extent of variability in steady-state viral load that can be explained by HLA-C alleles independent of HLA-B*57 was significantly lower than that reported previously [27]. Seventh, because of the aforementioned LD and genotype-phenotype patterns, we find that B*57-containing genotypes could be stratified into two categories, one of which associated with striking disease retardation, the other with a disease course that is similar to that observed in individuals who lack a B*57 allele. Finally, we found that B*57-containing genotypes that associate with a slower disease course influenced progression rates by impacting both the viral load as well as parameters that are independent of the viral load. Below, we discuss the seven major implications of these findings within the context of how they apply to AIDS pathogenesis, vaccine development, and genotype-phenotype association studies.
###end p 78
###begin p 79
###xml 58 63 58 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1</italic>
###xml 189 190 189 190 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 251 256 251 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1</italic>
###xml 260 265 260 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNF39</italic>
###xml 412 419 412 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 502 507 502 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1</italic>
###xml 542 549 542 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 572 584 572 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C/A10-</italic>
###xml 621 633 621 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C/A10-</italic>
###xml 726 738 726 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1-C/A10-</italic>
###xml 780 787 780 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 821 826 821 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1</italic>
###xml 928 935 928 935 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 1087 1094 1087 1094 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 1126 1130 1126 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-OBrien1">[46]</xref>
###xml 1146 1154 1146 1154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A*25</italic>
###xml 1169 1172 1169 1172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A10</italic>
###xml 1207 1211 1207 1211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-vanBaalen1">[47]</xref>
###xml 1213 1217 1213 1217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Klenerman1">[48]</xref>
###xml 1219 1223 1219 1223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Kurane1">[49]</xref>
###xml 1229 1237 1229 1237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A*26</italic>
###xml 1252 1255 1252 1255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A10</italic>
###xml 1306 1310 1306 1310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Goulder2">[50]</xref>
###xml 1415 1422 1415 1422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 1729 1734 1729 1734 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1</italic>
###xml 1895 1899 1895 1899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Brass1">[51]</xref>
###xml 67 70 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 186 189 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 357 360 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 983 986 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1479 1484 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1889 1894 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
First, our results provide a basis to clarify the role of ZNRD1 in HIV pathogenesis. Using several different analytical approaches we find that in the European American component of the HIV+ cohort we studied, associations of the alleles in or around ZNRD1 or RNF39 with disease progression are not attributable to an independent effect of these alleles on HIV disease course, but rather to their strong LD with HLA-A10 alleles. In the cohort studied, there was a higher proportion of subjects who had ZNRD1-containing haplotypes that lacked HLA-A10 than individuals with ZNRD1-C/A10-containing haplotypes. Despite this, ZNRD1-C/A10-lacking haplotypes were not associated with a slower rate of disease progression whereas the ZNRD1-C/A10-containing haplotypes were. Additionally, HLA-A10-containing genotypes that lacked ZNRD1 alleles were also associated with a slower disease course. Collectively, these findings suggest that HLA-A10 may be an important determinant of the rate of HIV disease progression in European Americans. Previous association studies also suggest that serogroup HLA-A10 may convey a protective effect [46]. Additionally, HLA-A*25 (a subtype of A10) is known to present gag epitopes [47], [48], [49], and HLA-A*26 (a subtype of A10) restricted gag responses have been also reported [50]. These prior reports in conjunction with our genetic epidemiologic findings invoke the possibility that HLA-A10 carriers elicit protective immune responses against key HIV-1-derived peptides, and consideration of this possibility might have value for understanding the host factors that influence AIDS pathogenesis and for vaccine development. Nevertheless, future studies are clearly warranted to clarify the role of ZNRD1 in AIDS pathogenesis as it was among the more than 250 candidate genes identified by a large-scale siRNA screen used to identify host factors required by HIV-1 [51].
###end p 79
###begin p 80
###xml 113 117 113 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5</italic>
###xml 122 127 122 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
###xml 204 212 204 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 239 245 239 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5-G</italic>
###xml 423 429 423 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5-G</italic>
###xml 496 500 496 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 582 588 582 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5-G</italic>
###xml 596 600 596 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Fellay1">[27]</xref>
###xml 638 642 638 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 710 716 710 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 717 719 717 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-C</italic>
###xml 728 736 728 736 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4</bold>
###xml 728 736 728 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g004"><bold>Figure 4</bold></xref>
###xml 777 781 777 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 786 792 786 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 793 795 793 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-C</italic>
###xml 848 856 848 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 958 962 958 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Smith1">[11]</xref>
###xml 964 968 964 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Carrington1">[12]</xref>
###xml 970 974 970 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Stephens1">[14]</xref>
###xml 976 980 976 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Hunt1">[17]</xref>
###xml 982 986 982 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Migueles1">[19]</xref>
###xml 988 992 988 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Migueles2">[20]</xref>
###xml 994 998 994 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Altfeld1">[21]</xref>
###xml 1000 1004 1000 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Navis1">[22]</xref>
###xml 1070 1076 1070 1076 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 1077 1079 1077 1079 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-C</italic>
###xml 1133 1137 1133 1137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 1225 1231 1225 1231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 1237 1241 1237 1241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5</italic>
###xml 1590 1594 1590 1594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Deeks1">[31]</xref>
###xml 1596 1600 1596 1600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Han1">[52]</xref>
###xml 1602 1606 1602 1606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Bailey2">[53]</xref>
###xml 1689 1695 1689 1695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 1701 1705 1701 1705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5</italic>
###xml 1819 1823 1819 1823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Fellay1">[27]</xref>
###xml 1958 1964 1958 1964 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 1970 1974 1970 1974 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5</italic>
###xml 2020 2024 2020 2024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-deBakker2">[54]</xref>
###xml 2290 2294 2290 2294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Fellay1">[27]</xref>
###xml 1574 1577 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1905 1908 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Second, our results may provide a basis to clarify the disease- or viral load-influencing effects of the SNPs in HCP5 and HLA-C. (i) In multivariate models, after accounting for the protective effects of HLA-B*57 alleles, we find that the HCP5-G appears to have detrimental effects on both viral load and disease progression. Thus, we surmise that when examined in isolation the true phenotypic effects associated with the HCP5-G allele might be obscured because of its strong LD with protective B*57 alleles. We propose that the protective associations detected previously for the HCP5-G allele [27] are perhaps due to a specific set of B*57-containing genotypes, i.e., those that are also homozygous for the HLA-C5'-C allele (Figure 4, group 3). (ii) Based on the LD between B*57 and HLA-C5'-C alleles and the significant beneficial influence of HLA-B*57-containing genotypes on viral restriction and disease course observed here and in many prior studies [11], [12], [14], [17], [19], [20], [21], [22], we suggest that the dominant protective effects attributable to HLA-C5'-C alleles may be because of their presence in specific B*57-containing genotypes. (iii) We suggest that the differences in the extent to which the HLA-C5' and HCP5 alleles explained the variability in the steady-state viral load detected in a natural history cohort versus that observed in the GWAS might relate to epidemiological considerations. The combined analysis of subjects who achieved a steady-state viral load and those who had virologic characteristics similar to those of spontaneous HIV controllers [31], [52], [53] might be one reason why such a strong association for viral load was detected for HLA-C5' and HCP5 alleles, yet these alleles were not among those detected when using disease progression as a phenotypic endpoint [27]. Consistent with this possibility, the preliminary results of a separate GWAS in HIV controllers also revealed an association between HLA-C5' and HCP5 alleles and restriction of viral replication [54]. We are mindful that other epidemiologic considerations might also contribute to differing genotype-phenotype associations. This could include the criteria used to define disease progression, which was rate of CD4 decline or time to initiation of HAART in the GWAS [27] versus a clinical endpoint used herein. Thus, it is conceivable that the varying (i) characteristics (e.g., ethnicity, risk behavior) of the subjects, (ii) selection criteria used for entry into the study as well as (iii) phenotypic endpoints used may collectively account for some of the differences in the results of the genotype-phenotype association studies.
###end p 80
###begin p 81
###xml 242 246 242 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-deBakker1">[32]</xref>
###xml 429 433 429 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-deBakker1">[32]</xref>
###xml 461 464 461 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 529 533 529 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Dorak1">[55]</xref>
###xml 535 539 535 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Tang1">[56]</xref>
###xml 560 563 560 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 700 704 700 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5</italic>
###xml 709 714 709 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
###xml 720 724 720 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Fellay1">[27]</xref>
###xml 839 847 839 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 858 861 858 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 935 941 935 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5-G</italic>
###xml 979 983 979 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Liu1">[57]</xref>
###xml 499 502 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Third, the LD patterns detected herein are not completely unanticipated because the MHC locus is known to have small recombination rates and a high degree of LD, hence, increasing the number of extended haplotypic blocks in this genomic area [32]. The nature of these extended haplotypes differ in their genetic composition and the prevalence of these extended haplotypes also vary significantly according to continent-of-origin [32]. Notably, several extended HLA haplotypes that have relevance to HIV-AIDS have been identified [55], [56]. LD with protective HLA alleles might provide a basis for why a large proportion of the SNPs identified in the GWAS were in the MHC locus, including additional HCP5 and HLA-C SNPs [27]. Similar considerations of LD might also have applicability to the inferences of GWAS for other diseases in which HLA-B*57 and other HLA alleles play pathogenic roles. For example, a recent GWAS implicated the HCP5-G allele as a determinant of psoriasis [57].
###end p 81
###begin p 82
###xml 107 111 107 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 224 228 224 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Migueles1">[19]</xref>
###xml 230 234 230 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Migueles2">[20]</xref>
###xml 236 240 236 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Navis1">[22]</xref>
###xml 242 246 242 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Bailey1">[42]</xref>
###xml 297 301 297 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 442 446 442 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Migueles1">[19]</xref>
###xml 463 467 463 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Navis1">[22]</xref>
###xml 512 513 512 513 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 537 541 537 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 577 583 577 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*5701</italic>
###xml 741 745 741 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Bailey1">[42]</xref>
###xml 782 790 782 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 998 1006 998 1006 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 1195 1199 1195 1199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Migueles2">[20]</xref>
###xml 1201 1205 1201 1205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Navis1">[22]</xref>
###xml 1235 1241 1235 1241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 1242 1256 1242 1256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">/HLA-B*57/HCP5</italic>
###xml 1518 1522 1518 1522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*57</italic>
###xml 509 512 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 717 722 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1357 1360 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Fourth, we provide a genetic basis for the long-standing but highly underappreciated conundrum of why some B*57-carrying individuals have a progressive disease course whereas others exhibit a strikingly slow clinical course [19], [20], [22], [42]. The prevailing viewpoint is that possession of a B*57 allele confers strong protection against early viral replication and disease progression. However, the studies especially of Migueles et al [19] and Navis et al [22] suggest that a substantial proportion of HIV+ subjects who possess a B*57 allele, including those possessing B*5701 can have a progressive disease course. A very striking example of this conundrum was reported recently by Bailey et al who studied a HIV-1 transmission pair [42]: while both transmission pairs were HLA-B*57 positive, the transmitter progressed to AIDS, whereas the recipient was an elite controller. The contrasting clinical phenotypes of nonprogressive vs progressive disease course associated with carriage of a HLA-B*57 allele has been attributed to differences in cytotoxic T lymphocyte (CTL) escape mutations and CTL activity against epitopes in Gag as well as to differential viral replication capacities [20], [22]. Here, we show that specific HLA-C5'/HLA-B*57/HCP5 containing genotypes may represent multiplex 'genetic signatures' that have differential effects on HIV disease course. These genetic findings have broad biologic and public health significance as the immunologic features linked to protective vs non-protective B*57-containing genotypes may have practical value in achieving a detailed understanding of the immunologic correlates of virologic control and nonprogressive disease.
###end p 82
###begin p 83
###xml 203 210 203 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 279 287 279 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 587 598 587 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCL3L1-CCR5</italic>
###xml 720 724 720 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Gonzalez3">[37]</xref>
###xml 726 730 726 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Ahuja1">[38]</xref>
###xml 990 994 990 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Dolan1">[39]</xref>
###xml 1023 1027 1023 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Rodriguez1">[44]</xref>
###xml 1029 1033 1029 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Henry1">[45]</xref>
###xml 1214 1218 1214 1218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Silvestri1">[58]</xref>
###xml 1564 1567 1564 1567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Desrosiers1">[2]</xref>
###xml 1594 1598 1594 1598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Anderson1">[23]</xref>
###xml 1600 1604 1600 1604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Blower1">[24]</xref>
###xml 1606 1610 1606 1610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-AbuRaddad1">[25]</xref>
###xml 1612 1616 1612 1616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Amirfar1">[26]</xref>
###xml 1812 1816 1812 1816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Rodriguez1">[44]</xref>
###xml 1818 1822 1818 1822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Henry1">[45]</xref>
###xml 1892 1896 1892 1896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Dolan1">[39]</xref>
###xml 1060 1065 <span type="species:ncbi:9606">human</span>
###xml 1107 1136 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
###xml 1356 1359 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Fifth, our findings place a spotlight on that aspect of pathogenesis that is influenced by parameters whose effects are independent of the viral burden. This point is illustrated by two observations (i) HLA-A10 affects disease course without influencing the viral load, and (ii) HLA-B*57-containing genotypes that convey a nonprogressive disease course do so partly by restricting viral replication (as reflected by the viral load) and also by impacting on parameters that are independent of the viral load. These observations are reminiscent of our previous results where we found that CCL3L1-CCR5 genotypes also influence disease progression, in part, by impacting on parameters that are independent of the viral load [37], [38]. Although the full nature of these viral load-independent parameters is as yet unknown, their importance in pathogenesis is inferred from (i) prior findings showing that the viral load does not explain the full extent of variability in AIDS progression rates [39] or rate of CD4 cell decline [44], [45], and (ii) findings in non-human primates who are naturally infected with simian immunodeficiency virus, as these animals exhibit a non-progressive disease despite high viral loads [58]. Hence, consideration of both the viral load and viral load-independent parameters might help mitigate the confounding that may occur in HIV vaccine and genetic-epidemiologic studies in which the viral load is used as the primary surrogate marker for vaccine efficacy or disease outcome, respectively. Additionally, findings from animal studies [2] and mathematical modeling [23], [24], [25], [26] support the hope that imperfect, T-cell based disease-modifying, i.e., therapeutic vaccines, by reducing plasma viral load at the population level might abate the epidemic. However, the clinical [44], [45], and genotype-phenotype relationships observed herein and previously [39] raise the possibility that for a therapeutic vaccine to be efficacious in mitigating disease progression rates, in addition to reducing the viral load, the vaccine may also need to target pathogenic viral load-independent factors.
###end p 83
###begin p 84
###xml 139 147 139 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 794 798 794 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Deeks1">[31]</xref>
###xml 828 832 828 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Migueles1">[19]</xref>
###xml 848 858 848 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*5701</italic>
###xml 1027 1033 1027 1033 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B*5701</italic>
###xml 1121 1131 1121 1131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*5701</italic>
###xml 1872 1876 1872 1876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Dolan1">[39]</xref>
###xml 1878 1882 1878 1882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Rodriguez1">[44]</xref>
###xml 1884 1888 1884 1888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Henry1">[45]</xref>
###xml 57 60 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 972 975 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1276 1279 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1307 1310 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1464 1472 <span type="species:ncbi:9606">patients</span>
###xml 1773 1776 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Sixth, within the context of a natural history cohort of HIV-positive individuals we find that there is a gradual enrichment of protective HLA-B*57 genotypes in subjects who remain AIDS free for a prolonged duration. This gradual shift emphasizes that the relative contribution of a genetic factor that confers the phenotype of nonprogressive disease within the context of a natural history cohort may not be identical to the contribution of the same genetic factor in subjects who are selected for analyses based on specific clinical characteristics such as those with nonprogessive disease (e.g., long-term nonprogressors), or virologic characteristics such as untreated subjects who maintain very low viral loads during some period of the disease course (e.g., elite or viremic controllers) [31]. For example, Migueles et al [19] found that the HLA-B*5701 allele is dramatically overrepresented in long-term nonprogressors. When studied within the context of a natural HIV history cohort, we find that 6.6% of EAs possess a B*5701 allele and of these 64% have progressive disease. Thus, the very high frequency of the HLA-B*5701 allele among those selected because of nonprogressive disease or a low viral load may represent an estimate specific to this selected subset of HIV-positive subjects, because HIV-positive individuals who have progressive disease are unlikely to be well represented in such a study group. Hence, association studies in such selected patients are more likely to identify genetic factors that are skewed towards having a significant impact on restriction of viral replication or nonprogressive disease, and may not necessarily identify the full realm of host factors that influence pathogenesis in the context of the natural clinical course of HIV disease, especially because a proportion of AIDS pathogenesis is independent of the viral load [39], [44], [45].
###end p 84
###begin p 85
###xml 161 165 161 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Gonzalez1">[34]</xref>
###xml 167 171 167 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Gonzalez2">[36]</xref>
###xml 237 241 237 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Winkler1">[35]</xref>
###xml 290 299 290 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A10/ZNRD1</italic>
###xml 301 306 301 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
###xml 311 315 311 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5</italic>
###xml 1058 1062 1058 1062 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCL5</italic>
###xml 1163 1169 1163 1169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-46C/C</italic>
###xml 1221 1225 1221 1225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DARC</italic>
###xml 1337 1341 1337 1341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-He1">[43]</xref>
###xml 100 103 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 616 619 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1588 1591 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1633 1636 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Finally, the results of the present study support our previous thesis that the host determinants of HIV pathogenesis are likely to be highly population-specific [34], [36]. Similar inferences were also reported by Winkler and colleagues [35]. In this study, we found that the impact of the A10/ZNRD1, HLA-C and HCP5 alleles on disease course were evident mainly in subjects of European descent. Some of these race-specific effects are not related to the differential distribution in the frequency of these polymorphisms in European and African Americans. The exact basis for these race/ethnicity-specific effects on HIV disease is unclear. Given the differing evolutionary histories of the populations examined, one possibility is that the race/ethnicity-specific effects observed might relate to the interplay between polymorphisms in different gene systems that played an ancestral role in the contrasting host-microbe interplay found in subjects of European and African descent. For example, we found recently that the disease-accelerating effects of the CCL5 -471A/A genotype in African Americans is evident only in those who do not bear the African-specific -46C/C genotype of Duffy Antigen Receptor for Chemokines (DARC), a genotype which is thought to have arisen due to the selective pressure of specific malaria-causing species [43]. Regardless of the precise reasons for the observed race-specific effects, they add a tier of underappreciated complexity as they point to population-specific correlates of protection. Consequently, the development and evaluation of an effective HIV vaccine might need to factor in not just HIV diversity, but also host genetic diversity.
###end p 85
###begin title 86
Methods
###end title 86
###begin title 87
Study subjects
###end title 87
###begin p 88
###xml 673 677 673 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Gonzalez1">[34]</xref>
###xml 679 683 679 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Gonzalez2">[36]</xref>
###xml 685 689 685 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Gonzalez3">[37]</xref>
###xml 691 695 691 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Ahuja1">[38]</xref>
###xml 697 701 697 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Dolan1">[39]</xref>
###xml 703 707 703 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Gonzalez4">[59]</xref>
###xml 709 713 709 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Catano1">[60]</xref>
###xml 715 719 715 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003636-Burt1">[61]</xref>
###xml 0 3 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 64 67 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 399 402 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 531 534 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 616 619 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
HIV-positive subjects were from the Department of Defense (DoD) HIV Natural History Study (NHS) cohort followed at Wilford Hall Medical Center (WHMC) and more recently at the Brooke Army Medical Center (BAMC), San Antonio, TX. The studied population is the local component of a prospective multisite observational cohort from the United States Military's Tri-Service AIDS Clinical Consortium (TACC) HIV Natural History Study. Unidentified cast-off blood from subjects participating in training at Lackland AFB, TX was used for the HIV-negative control population. The demographic and clinical characteristics of the HIV-positive WHMC cohort have been described extensively [34], [36], [37], [38], [39], [59], [60], [61]. The voluntary, fully written informed consent of the subjects studied in this research was obtained as required by Air Force Regulation 169-9 and additional approval from the Institutional Review Board (IRB) of the University of Texas Health Science Center, San Antonio, TX.
###end p 88
###begin title 89
Genotyping
###end title 89
###begin p 90
###xml 15 23 15 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 28 38 28 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*5701</italic>
###xml 75 76 75 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 108 112 108 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5</italic>
###xml 126 132 126 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 175 180 175 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1</italic>
###xml 181 186 181 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RNF39</italic>
###xml 194 203 194 203 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1A</bold>
###xml 194 203 194 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003636-g001"><bold>Figure 1A</bold></xref>
###xml 232 233 232 233 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 296 303 296 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 325 330 325 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1</italic>
###xml 359 367 359 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 369 373 369 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5</italic>
###xml 378 384 378 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C5</italic>
###xml 585 597 585 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003636.s001">Materials S1</xref>
###xml 72 75 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 229 232 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 253 256 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Genotyping for HLA-B*57 and HLA-B*5701 subtypes was undertaken in 1,143 HIV+ subjects. Polymorphisms in the HCP5 (rs2395029), HLA-C5' (rs9264942) and seven SNPs in and around ZNRD1-RNF39 genes (Figure 1A) were genotyped in 1,230 HIV+ subjects and 1,129 HIV-negative subjects. Haplotypes based on HLA-A10 status and the seven ZNRD1 SNPs as well those based on HLA-B*57, HCP5 and HLA-C5' alleles were generated using unphased data. For this purpose, we used the PHASE software. Detailed materials, methods and description of the study cohort are available as supporting online material (Materials S1).
###end p 90
###begin title 91
Supporting Information
###end title 91
###begin p 92
(0.20 MB DOC)
###end p 92
###begin p 93
Click here for additional data file.
###end p 93
###begin p 94
###xml 62 65 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Disease-influencing effects associated with HLA-A10 status in HIV-positive EA subjects from the WHMC cohort who had not received HAART.
###end p 94
###begin p 95
(0.26 MB TIF)
###end p 95
###begin p 96
Click here for additional data file.
###end p 96
###begin p 97
###xml 58 61 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Association between HLA-A10-ZNRD1 haplotypes and rates of HIV disease progression in the EA component of the WHMC cohort.
###end p 97
###begin p 98
(0.58 MB TIF)
###end p 98
###begin p 99
Click here for additional data file.
###end p 99
###begin p 100
###xml 63 66 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Association between HLA-C5'-HLA-B-HCP5 haplotypes and rates of HIV disease progression in the WHMC cohort.
###end p 100
###begin p 101
(1.06 MB TIF)
###end p 101
###begin p 102
Click here for additional data file.
###end p 102
###begin p 103
Disease-influencing effects associated with HLA-B*57-NPD and HLA-B*57-PD genotypes in subjects who had not received HAART.
###end p 103
###begin p 104
(0.33 MB TIF)
###end p 104
###begin p 105
Click here for additional data file.
###end p 105
###begin p 106
We thank S. Wegner and other members of the Infectious Disease Clinical Research Program (IDCRP) for critical support of this work. We thank D. Hepp and C. Crosby for technical assistance, and A. S. Ahuja for forbearance. The opinions or assertions contained herein are the private views of the authors, and are not to be construed as official, or as reflecting the views of the Departments of the Army, Navy, Air Force, or the Department of Defense.
###end p 106
###begin title 107
References
###end title 107
###begin article-title 108
###xml 3 6 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
An HIV vaccine-evolving concepts.
###end article-title 108
###begin article-title 109
Prospects for an AIDS vaccine.
###end article-title 109
###begin article-title 110
Toward an AIDS vaccine.
###end article-title 110
###begin article-title 111
###xml 5 8 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
AIDS/HIV. A STEP into darkness or light?
###end article-title 111
###begin article-title 112
###xml 11 14 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?
###end article-title 112
###begin article-title 113
AIDS research. Promising AIDS vaccine's failure leaves field reeling.
###end article-title 113
###begin article-title 114
AIDS Vaccine Trials:Considerations for Phase III Trial Design and Endpoints N, NIH, Nov. 16, 2001, http://www.niaid.nih.gov/vrc/pdf/p3trialsend.pdf
###end article-title 114
###begin article-title 115
###xml 32 60 <span type="species:ncbi:12721">human immunodeficiency virus</span>
What constitutes efficacy for a human immunodeficiency virus vaccine that ameliorates viremia: issues involving surrogate end points in phase 3 trials.
###end article-title 115
###begin article-title 116
###xml 83 86 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Sensitivity analysis for the assessment of causal vaccine effects on viral load in HIV vaccine trials.
###end article-title 116
###begin article-title 117
###xml 29 34 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Estimating the benefit of an HIV-1 vaccine that reduces viral load set point.
###end article-title 117
###begin article-title 118
###xml 22 25 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Genetic influences on HIV infection: implications for vaccine development.
###end article-title 118
###begin article-title 119
The influence of HLA genotype on AIDS.
###end article-title 119
###begin article-title 120
###xml 60 65 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis.
###end article-title 120
###begin article-title 121
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 diversity versus HLA class I polymorphism.
###end article-title 121
###begin article-title 122
###xml 57 60 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Influence of host genetic variation on susceptibility to HIV type 1 infection.
###end article-title 122
###begin article-title 123
Impact of MHC class I diversity on immune control of immunodeficiency virus replication.
###end article-title 123
###begin article-title 124
###xml 29 32 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Host genetic determinants of HIV pathogenesis: an immunologic perspective. Immune correlates of protection, activation and exhaustion.
###end article-title 124
###begin article-title 125
###xml 50 78 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Host factors associated with outcome from primary human immunodeficiency virus-1 infection. .
###end article-title 125
###begin article-title 126
###xml 87 90 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors.
###end article-title 126
###begin article-title 127
###xml 93 121 <span type="species:ncbi:12721">human immunodeficiency virus</span>
The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences.
###end article-title 127
###begin article-title 128
###xml 77 82 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection.
###end article-title 128
###begin article-title 129
###xml 85 90 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Viral replication capacity as a correlate of HLA B57/B5801-associated nonprogressive HIV-1 infection.
###end article-title 129
###begin article-title 130
###xml 44 47 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Potential public health impact of imperfect HIV type 1 vaccines.
###end article-title 130
###begin article-title 131
###xml 26 29 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Forecasting the future of HIV epidemics: the impact of antiretroviral therapies & imperfect vaccines.
###end article-title 131
###begin article-title 132
###xml 77 80 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Analytic insights into the population level impact of imperfect prophylactic HIV vaccines.
###end article-title 132
###begin article-title 133
###xml 45 48 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 60 63 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 90 95 <span type="species:ncbi:9606">women</span>
###xml 100 107 <span type="species:ncbi:9606">infants</span>
Modeling the impact of a partially effective HIV vaccine on HIV infection and death among women and infants in South Africa.
###end article-title 133
###begin article-title 134
###xml 75 80 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A whole-genome association study of major determinants for host control of HIV-1.
###end article-title 134
###begin article-title 135
###xml 64 69 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection.
###end article-title 135
###begin article-title 136
###xml 13 18 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Prognosis in HIV-1 infection predicted by the quantity of virus in plasma.
###end article-title 136
###begin article-title 137
###xml 98 101 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Killer immunoglobulin-like receptors and HLA act both independently and synergistically to modify HIV disease progression.
###end article-title 137
###begin article-title 138
###xml 0 28 <span type="species:ncbi:12721">Human immunodeficiency virus</span>
Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy.
###end article-title 138
###begin article-title 139
###xml 92 97 <span type="species:ncbi:9606">human</span>
A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC.
###end article-title 139
###begin article-title 140
###xml 52 57 <span type="species:ncbi:9606">human</span>
A high-resolution linkage-disequilibrium map of the human major histocompatibility complex and first generation of tag single-nucleotide polymorphisms.
###end article-title 140
###begin article-title 141
###xml 14 19 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes.
###end article-title 141
###begin article-title 142
Patterns of ethnic diversity among the genes that influence AIDS.
###end article-title 142
###begin article-title 143
###xml 102 107 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: impact on the epidemiology of the HIV-1 pandemic.
###end article-title 143
###begin article-title 144
###xml 66 71 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility.
###end article-title 144
###begin article-title 145
###xml 95 100 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individuals.
###end article-title 145
###begin article-title 146
###xml 60 63 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms.
###end article-title 146
###begin article-title 147
Immunobiology of HLA;
###end article-title 147
###begin article-title 148
###xml 129 137 <span type="species:ncbi:9606">children</span>
###xml 161 189 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Concordance between the CC chemokine receptor 5 genetic determinants that alter risks of transmission and disease progression in children exposed perinatally to human immunodeficiency virus.
###end article-title 148
###begin article-title 149
###xml 16 51 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 59 66 <span type="species:ncbi:9606">patient</span>
Transmission of human immunodeficiency virus type 1 from a patient who developed AIDS to an elite suppressor.
###end article-title 149
###begin article-title 150
###xml 66 71 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 121 124 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility.
###end article-title 150
###begin article-title 151
###xml 27 30 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 84 87 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection.
###end article-title 151
###begin article-title 152
###xml 37 40 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Explaining, predicting, and treating HIV-associated CD4 cell loss: after 25 years still a puzzle.
###end article-title 152
###begin article-title 153
HLA and AIDS: a cautionary tale.
###end article-title 153
###begin article-title 154
###xml 101 136 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Fine-specificity of cytotoxic T lymphocytes which recognize conserved epitopes of the Gag protein of human immunodeficiency virus type 1.
###end article-title 154
###begin article-title 155
Identification of a novel HLA-A25-restricted epitope in a conserved region of p24 gag (positions 71-80).
###end article-title 155
###begin article-title 156
###xml 34 69 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 96 101 <span type="species:ncbi:9606">human</span>
Definition of two new epitopes on human immunodeficiency virus type 1 gag protein recognized by human CD8+ cytotoxic T lymphocyte clones.
###end article-title 156
###begin article-title 157
###xml 26 31 <span type="species:ncbi:9606">human</span>
Identification of a novel human leukocyte antigen A26-restricted epitope in a conserved region of Gag.
###end article-title 157
###begin article-title 158
###xml 45 48 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Identification of host proteins required for HIV infection through a functional genomic screen.
###end article-title 158
###begin article-title 159
###xml 81 86 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The role of protective HCP5 and HLA-C associated polymorphisms in the control of HIV-1 replication in a subset of elite suppressors.
###end article-title 159
###begin article-title 160
###xml 36 41 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Maintenance of viral suppression in HIV-1-infected HLA-B*57+ elite suppressors despite CTL escape mutations.
###end article-title 160
###begin article-title 161
###xml 35 38 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
A genome-wide association study in HIV Elite Controllers to identify host genetic factors that influence viral control in the absence of anti-retroviral therapy.
###end article-title 161
###begin article-title 162
Conserved extended haplotypes of the major histocompatibility complex: further characterization.
###end article-title 162
###begin article-title 163
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 70 73 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Human leukocyte antigen class I genotypes in relation to heterosexual HIV type 1 transmission within discordant couples.
###end article-title 163
###begin article-title 164
A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease Loci.
###end article-title 164
###begin article-title 165
###xml 35 38 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
Understanding the benign nature of SIV infection in natural hosts.
###end article-title 165
###begin article-title 166
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels.
###end article-title 166
###begin article-title 167
###xml 92 95 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Independent effects of genetic variations in mannose-binding lectin influence the course of HIV disease: the advantage of heterozygosity for coding mutations.
###end article-title 167
###begin article-title 168
###xml 33 38 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 112 115 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression.
###end article-title 168
###begin p 169
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 169
###begin p 170
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
###xml 83 86 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Funding: This work was supported by the Veterans Administration Center on AIDS and HIV Infection of the South Texas Veterans Health Care System, and by a MERIT award (R37046326) and other awards (AI043279 and MH069270) from the NIH (to S.K.A.). S.K.A. is a recipient of the Elizabeth Glaser Scientist Award and the Burroughs Wellcome Clinical Scientist Award in Translational Research. Support for the WHMC cohort was provided by the Infectious Disease Clinical Research Program (IDCRP) of the Uniformed Services University of the Health Sciences (USUHS), of which the Tri-Service AIDS Clinical Consortium (TACC) is a component. The IDCRP is a Department of Defense tri-service program executed through USUHS and the Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF), in collaboration with HHS/NIH/NIAID/DCR through Interagency Agreement HU0001-05-2-0011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 170

